Cognitive dysfunction and mental health status in ketamine and poly-drug abusers. by Liang, Huajun. & Chinese University of Hong Kong Graduate School. Division of Medical Sciences.
Cognitive Dysfunction and Mental Health Status 
in Ketamine and Poly-drug Abusers 
LIANG, Huajun 
A Thesis Submitted in Partial Fulfilment 
of the Requirements for the Degree of 
Doctor of Philosophy 
in 
Medical Sciences 
The Chinese University of Hong Kong 
July 2013 

DECLARATION OF ORIGINALITY 
The work contained in this thesis is original research carried out by the 
author in the Department of Psychiatry, Faculty of Medicine, the Chinese 
University of Hong Kong. No part of the thesis has been submitted to other 
universities or institutions for the purpose of being awarded a degree or 
diploma. 
ACKNOWLEDGEMENTS 
I would like to express my sincere gratitude to my supervisor, Professor W.K. 
Tang, for his professional guidance and continual encouragement throughout the 
three years of my PhD study. His dedication and enthusiasm for scientific research 
have been inspiring. The progress I have made in my work can be largely 
attributed to his patience and enthusiasm. I sincerely thank my supervisor for his 
support in my thesis work. 
I would also like to thank my colleagues Dr Alan Tang, Dr Chan Fu and Ms 
Grace Lau for their ongoing assistance. 
I am very grateful to the following agencies for their support in participant 
recruitment for this study: Caritas HUGS Centre; Caritas Lok Heep Club; Cheer 
Lutheran Centre, Hong Kong Lutheran Social Services; Christian New Life 
Association; Evergreen Lutheran Centre, Hong Kong Lutheran Social Services; 
Hong Kong Christian Service PS33 - Shamshuipo Centre; Hong Kong Christian 
Service PS33 - Tsimshatsui Centre; Hong Kong North District Hospital UROK 
Clinic; Hong Kong Sheng Kung Hui Welfare Council Neo-Horizon; Jockey Club 
Ma On Shan (South) Children & Youth Integrated Service Centre, Hong Kong 
Sheng Kung Hui Welfare Council; Jockey Club Wah Ming Lutheran Integrated 
Service Centre, Hong Kong Lutheran Social Services; Jockey Club Yung Shing 
Lutheran Integrated Service Centre, Hong Kong Lutheran Social Services; 
Operation Dawn; Rainbow Lutheran Centre, Hong Kong Lutheran Social Services; 
II 
Sha Tin Youth Outreaching Social Work Team, Chinese Young Men's Christian 
Association of Hong Kong; The Society for the Aid and Rehabilitation of Drug 
Abusers; Yuen Long District Youth Outreaching Social Work Team; and Hong 
Kong Christian Service. I also need to thank all of the subjects who volunteered for 
this study. They are the most important part. 
Finally, I reserve my deepest gratitude for my parents, my husband and my 
elder sister. It is their understanding and great support that have allowed me to 
concentrate on my academic career. 
III 
PUBLICATIONS AND PRESENTATIONS 
Journal papers (9 papers) 
Part one: Papers related to the thesis: 
1. Tang AK, Tang WK, Liang HJ, Chan F, Mak SC, Ungvari GS. Clinical 
characteristics of cough mixture abusers referred to three substance abuse 
clinics in Hong Kong: a retrospective study. East Asian Archives of 
Psychiatry. Accepted on 30 July 2012. 
2. Tang A, Cheung RY, Liang HJ, Ungvari GS, Tang WK. Psychiatric 
morbidity at a female residential drug treatment centre in Hong Kong. 
East Asian Archives of Psychiatry. 2011; 21(1):22-27. 
3. Tang A, Liang HJ, Ungvari GS, Tang WK. Referral patterns and clinical 
characteristics of clients referred to the PWH Substance Abuse Clinic. 
East Asian Archives of Psychiatry. 2011; 21(1):28-31. 
4. Tang WK, Liang HJ, Lau CG, Tang A, Ungvari GS. Relationship 
between cognitive impairment and depressive symptoms in current 
ketamine users. Journal of Studies on Alcohol and Drugs. Submitted on 
October 2012. 
5. HJ Liang, CG Lau, A Tang, F Chan, GS Ungvari, WK Tang. Cognitive 
impairments in current and ex-ketamine plus poly-drug users. In 
preparation. 
I V 
Part two: Papers not related to the thesis: 
1. Tang WK, Chen YK, Lu JY, Liang HJ, Chu CCW, Mok VCT, Ungvari 
GS, Wong KS. Frontal infarcts and anxiety in stroke. Stroke. 2012 May; 
43(5):1426-8. 
2. Tang WK, Tang N, Liao CD, Liang HJ, Mok VCT, Ungvari GS, Wong 
KS. Serotonin receptor 2C gene polymorphism in Chinese patients with 
poststroke depression. Genetics and Molecular Research. Accepted on 20 
June 2012. 
3. Tang WK, Chen YK, Liang HJ, Chu CCW, Mok VCT, Ungvari GS, 
Wong KS. Cerebral microbleed and suicidality in stroke. Psychosomatics 
2012; 53(5):439-45. 
4. Tang WK, Lu JY, Liang HJ, Chan TT, Mok VCT, Ungvari GS, Wong 
KS. Is insomnia associated with suicidality in stroke? Archives of 
Physical Medicine and Rehabilitation 2011; 92(8):1336-38. 
V 
Presentations at academic conferences 
Part one: Presentations related to this study 
1. HJ Liang, Alan Tang, WK Tang. Referral patterns and clinical 
characteristics of clients referred to the PWH Substance Abuse Clinic. The 
Third Joint International Conference of the Hong Kong College of 
Psychiatrists and the Royal College of Psychiatrists (UK). 9 December 
2012, Hong Kong. 
2. HJ Liang, WK Tang, M Lam, AWN Leung, WZ Sun, TT Chan, GS 
Ungvari. Traditional Chinese medicine diagnoses in persons with ketamine 
abuse. The Third Joint International Conference of the Hong Kong College 
of Psychiatrists and the Royal College of Psychiatrists (UK). 9 December 
2012, Hong Kong. 
3. AK Tang, WK Tang, HJ Liang, GS Ungvari. Epidemiology, clinical 
characteristics, and outcome of clients referred to the Prince of Wales 
Hospital Postnatal Depression Clinic. The Third Joint International 
Conference of the Hong Kong College of Psychiatrists and the Royal 
College of Psychiatrists (UK). 9 December 2012, Hong Kong. 
4. Liang HJ, Tang A, Tang WK. Cognitive dysfunction in primarily ketamine 
users. The 3rd Asian Pacific Problem Gambling and Addictions 
Conference, 2-3 June 2011, Hong Kong. 
V I 
5. Tang A, Liang HJ, Tang WK. Cognitive dysfunction in primarily ketamine 
users. International Congress of the International Federation of Psychiatric 
Epidemiology, 30 March-2 April 2011, Kaohsiung, Taiwan. 
6. Tang AKL, Liang HJ, Tang WK. Cognitive dysfunction in primarily 
ketamine users. The Second Joint International Conference of the Hong 
Kong College of Psychiatrists and the Royal College of Psychiatrists (UK), 
11-13 December 2010, Hong Kong. East Asian Archives of Psychiatry, 
2010; 20(4), supplement:25-26. 
7. Tang A, Cheung RYK, Liang HJ, Ungvari GS, Tang WK. Psychiatric 
morbidity at a female residential drug treatment centre in Hong Kong. The 
2011 Institute of Mental Health Conference, 2-3 September 2011, Hong 
Kong. East Asian Archives of Psychiatry, 2011 March; 21(1):28-31. 
8. Tang A, Liang HJ, Tang WK. Referral patterns and clinical characteristics 
of clients referred to the PWH Substance Abuse Clinic. The 3rd Asian 
Pacific Problem Gambling and Addictions Conference, 2-3 June 2011, 
Hong Kong. 
9. Tang A, Liang HJ, Tang WK. Referral patterns and clinical characteristics 
of clients referred to the PWH Substance Abuse Clinic. International 
Congress of the International Federation of Psychiatric Epidemiology, 30 
March-2 April 2011, Kaohsiung, Taiwan. 
10. Tang A, Cheung RYK, Liang HJ, Ungvari GS, Tang WK. Psychiatric 
morbidity at a female residential drug treatment centre in Hong Kong. 
V I I 
International Congress of the International Federation of Psychiatric 
Epidemiology, 30 March-2 April 2011, Kaohsiung, Taiwan. 
11. Tang A, Liang HJ, Ungvari GS, Tang WK. Referral patterns and clinical 
characteristics of subjects referred to the Prince of Wales Hospital 
Substance Abuse Clinic. The 2011 Institute of Mental Health Conference, 
2-3 September 2011, Hong Kong. East Asian Archives of Psychiatry, 2011 
March; 21(1):22-7. 
12. Chan F, Tang AKL, Liang HJ, Tang WK. Psychiatric morbidity at a 
female residential drug treatment centre in Hong Kong. The Second Joint 
International Conference of the Hong Kong College of Psychiatrists and 
the Royal College of Psychiatrists (UK), 11-13 December 2010, Hong 
Kong. East Asian Archives of Psychiatry 2010; 20(4), supplement:83 
13. Liang HJ, Tang A, Tang WK. Referral patterns and clinical characteristics 
of clients referred to the PWH Substance Abuse Clinic. The Second Joint 
International Conference of the Hong Kong College of Psychiatrists and 
the Royal College of Psychiatrists (UK), 11-13 December 2010, Hong 
Kong. East Asian Archives of Psychiatry 2011; 21(1):28-31. 
14. Tang A, Tang WK, Liang HJ. Trends of substance misuse and clinical 
psychiatric morbidity in Hong Kong. International Symposium on 
Substance Abuse, 13-14 May 2010, Tainan, Taiwan. 
V I I I 
Part two: Presentations not related to this study 
1. WK Tang, YK Chen, JY Lu, HJ Liang, WCW Chu, VCT Mok, GS 
Ungvari, KS Wong. Cerebral microbleeds and suicidality in stroke. The 
Third Joint International Conference of the Hong Kong College of 
Psychiatrists and the Royal College of Psychiatrists (UK), 9 December 
2012, Hong Kong. 
2. Lau CG, Tang WK, Liang HJ, Tang A, Ungvari GS. Six-month outcomes 
for patients attending a substance abuse clinic in Hong Kong. The 2011 
Institute of Mental Health Conference, 2-3 September 2011, Hong Kong. 
3. Liang HJ, Tang WK, Chen YK, Lu JY, Wong A, Mok, V, Chu WCW, 
Ungvari GS, Wong KS. Absence of cerebral microbleeds predicts reversion 
of vascular cognitive impairment no dementia in stroke. The Fifth 
International Congress of the Asian Society Against Dementia, 5-6 
November 2011, Hong Kong. 
4. Liang HJ, Chu WC, Mok V, Wong KS, Tang WK. Remission of 
poststroke cognitive impairment no dementia: clinical and imaging 
correlates. Sixth International Symposium on Healthy Aging: "A New 
Golden Age”, 5-6 March 2011, Hong Kong. 
5. Liang HJ, Chu WC, Mok V, Wong KS, Tang WK. White matter 
hyperintensities predict dementia in poststroke patients with cognitive 
impairment no dementia (CIND). Sixth International Symposium on 
Healthy Aging: “A New Golden Age", 5-6 March 2011, Hong Kong. 
I X 
Tang AK, Liang HJ, Ungvari GS, Tang WK. Screening of psychiatric 
morbidity in the postpartum period: clinical presentation and outcome at 
one-year follow-up. 2nd Focus in O&G, 11-12 June 2011, Hong Kong. 
Tang AKL, Liang HJ, Ungvari GS, Tang WK. Clinical characteristics and 
outcome of clients referred to the Prince of Wales Hospital (PWH) 
Postnatal Depression (PND) Clinic. The Second Joint International 
Conference of the Hong Kong College of Psychiatrists and the Royal 
College of Psychiatrists (UK), 11-13 December 2010, Hong Kong. East 
Asian Archives of Psychiatry, 2010; 20(4), supplement:70 
X 
LIST OF ABBREVIATIONS 
ASI: The Addiction Severity Index 
BDI: Beck Depression Inventory 
BPRS: The Brief Psychiatric Rating Scale 
CCPSA: Counselling Centres for Psychotropic Substance Abusers 
CHC: Cattell-Horn-Carroll 
CK: Current primarily ketamine user 
CPK: Current poly-drug ketamine user 
C-SCID: Chinese Version Structured Clinical Interview for DSM-IV 
DSC: Digit-Symbol Coding 
DSB: Digit Span Backward 
DSF: Digit Span Forward 
DSM-IV: Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition 
EK: Ex-primarily ketamine user 
EPK: Ex-poly-drug ketamine user 
FC: Female control 
FK: Female primarily ketamine user 
GABA: Gamma-aminobutyric acid 
HADSA: Hospital Anxiety Depression Scale. 
HC: Healthy control group 
IQ: Intelligence Quotient 
X I 
KAIT: Kaufman Adolescent and Adult Intelligence Test 
LTP: Long-term potentiation 
MC: Male control 
MK: Male primarily ketamine user 
MVFT: Modified Verbal Fluency Test 
NMDAR: N-Methyl-D-aspartate receptor 
NGO: Non-governmental organisation 
PCP: Phencyclidine 
PFC: Prefrontal cortex 
Poly K: Poly-drug ketamine group 
Primarily K: Primarily ketamine group 
RA: Research assistants 
RIAS: Reynolds Intellectual Assessment Scales 
ROCF: Rey-Osterrieth Complex Figure 
SB5: Stanford-Binet Intelligence Scales, Fifth Edition 
SDS: Severity of Dependence Scale 
VF: Verbal fluency 
WAIS-III: Wechsler Adult Intelligence Scale-Third Edition 
WAIS: Wechsler Adult Intelligence Test 
WCST: Wisconsin Card Sorting Test 
WJ-III: Woodcock-Johnson III Test of Cognitive Abilities 
WMS-III: Wechsler Memory Scale-Third Edition. 
X I I 
LIST OF TABLES AND FIGURES 
Table 1 Subtests grouped according to the WAIS-III factor structure 26 
Table 2 Cognitive battery 42 
Table 3 Descriptive statistics of demographic characteristics 46 
Table 4 Descriptive statistics of drug use patterns among groups 48 
Table 5 Patterns of drug use 50 
Table 6 Psychiatric problems among three groups 53 
Table 7 Performance on cognitive tests among three groups 56 
Table 8 Correlation of drug use pattern and memory in primarily ketamine group 
59 
Table 9 Demographics and reported estimates of ketamine use in the two 
Primarily K and HC groups 61 
Table 10 Reported estimates of use of drugs apart from ketamine by current and 
ex-Primarily K users 62 
Table 11 Group scores on cognitive assessments, comparison of current users, 
ex-primarily ketamine users and healthy controls 66 
Table 12 Correlations between BDI and cognitive assessment scores in current 
ketamine users (N = 51) 68 
Table 13 Group scores on demographics and drug use patterns, comparison of 
current poly-ketamine users, ex-poly-drug ketamine users and healthy controls 71 
Table 14 Group scores on cognitive assessments, comparison of current 
poly-ketamine users, ex-poly-ketamine users and healthy controls 72 
Table 15 Comparisons of demographics and drug use patterns among current 
primarily ketamine users, current poly-ketamine users and healthy controls 76 
Table 16 Comparisons of cognitive function among current primarily ketamine 
users, current poly-ketamine users and healthy controls 78 
Table 17 Comparisons of demographics and drug use patterns among female and 
male primarily ketamine users and healthy controls 82 
X I I I 
Table 18 Comparisons of cognitive function among female primarily ketamine 
users, male primarily ketamine users and healthy controls 84 
Figure 1 Study procedure 30 
X I V 
ABSTRACT 
Abstract of thesis entitled 
Cognitive Dysfunction and Mental Health Status in Ketamine and 
Poly-drug Abusers 
Submitted by LIANG Huajun 
for the degree of Doctor of Philosophy in Medical Sciences 
at the Chinese University of Hong Kong in November 2012 
X V 
The objective of this study was to evaluate the long-term effect of ketamine 
use on both the cognition and psychological well-being of youths in Hong Kong. 
Three hundred participants were recruited for the study, which lasted from 
December 2009 to December 2011. Participants were divided into three groups of 
100 each: primarily ketamine (Primarily K) users, poly-drug ketamine (Poly K) 
users and healthy controls (HCs). Psychiatric assessments included screening with 
self-rating questionnaires and face-to-face interviews. All participants completed a 
detailed cognitive battery covering general intelligence, verbal memory, visual 
memory, executive function, motor speed and language. 
The participants in the Primarily K group predominantly used ketamine, 
whereas those in the Poly K group used ketamine in addition to secondary drugs, 
of which cocaine and methamphetamine were the most frequent. Depressive 
disorder was the most common psychiatric disorder in both ketamine groups. 
Univariate analysis also showed the two ketamine groups to score poorly on most 
of the cognitive tests relative to the HC group. After adjusting for age, sex, 
education and Beck Depression Inventory (BDI) score, verbal and visual memory 
remained impaired in both ketamine groups in comparison with the HC group. 
Ketamine use in the past month was independently related to memory impairment 
in the Primarily K group. In subgroup analyses of Primarily K users, verbal and 
visual memory, motor speed, and some of the executive function indexes were 
significantly impaired in current users but not in ex-users. These findings suggest 
that the cognitive influence of ketamine is reversible. Moreover, the current 
X V I 
ketamine users had a higher BDI score than the ex-users or HCs. However, the ex-
and current poly-drug ketamine users exhibited a similar degree of memory 
impairment compared with the HCs. The female Primarily K users showed more 
visual memory impairment than their male counterparts, although females 
generally performed better than males in verbal memory. 
In conclusion, the use of ketamine alone and in conjunction with other 
psychotropic drugs is associated with deficits in memory and executive function. 
The observed memory impairment was related primarily to recent ketamine use, 
with current Primarily K users presenting with a more severe memory deficit than 
current Poly K users. However, the Primarily K group realised improvement in 
cognitive impairment after abstaining from ketamine, whereas the Poly K group 
did not. In addition to cognitive functioning difficulties, more than half of the 
ketamine users suffered from depressive disorder. Moreover, the findings suggest 
that women may be more sensitive than men to visual memory impairment 
following chronic ketamine use. The findings of this study will be helpful in 
treating ketamine abuse, and reinforce the efficacy of abstinence from drugs. 
Further longitudinal research is needed to determine the reversibility of ketamine's 
effects and the mechanism by which that reversibility takes place. Further study is 
also needed to clarify the drug's sex-specific effects. 
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CHAPTER 1 BACKGROUND 1.1 Introduction to ketamine and ketamine misuse 
CHAPTER 1 BACKGROUND 
1.1 Introduction to ketamine and ketamine misuse 
The anaesthetic ketamine 
[2-(2-chlorophenyl)-2-(methylamine)-cydohexanone] was developed by 
Parke-Davis Laboratories in the United States in 1962 as a replacement for 
phencyclidine (PCP). Ketamine's effect is less potent than PCP's, and has a shorter 
duration. It is known to have a ‘dissociative effect', and its most common, albeit 
relatively rare, side effect is hypotension. Ketamine is legally used in human 
analgesia in settings ranging from paediatrics to trauma and cancer, and is also 
commonly used in veterinary practice [Wolff and Winstock 2006]. 
Ketamine reacts pharmacologically by non-competitively antagonising the 
N-methyl-D-aspartate (NMDA) receptor [Wolff and Winstock 2006]. NMDA 
receptor (NMDAR) antagonists may interfere with the transmission of excitatory 
amino acid glutamate and aspartate, which may underlie their inhibition of 
auditory perception, visual or painful stimuli, and environmental responses and 
their effects on memory. Ketamine enhances neurotransmission in the 
noradrenaline, serotonin and dopamine system in a dose-dependent fashion, which 
leads to its psychotomimetic and sympathomimetic effects [Wolff and Winstock 
2006] and addiction potential [Ross and Peselow 2009]. Ketamine can be 
effectively administered through the intranasal, intravenous, subcutaneous, 
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intramuscular and intrathecal routes. In recreational users, the intranasal route is 
the most common, as it results in rapid initiation and a long-lasting effect (2-3 
hours). A low dose (50-100 mg) generally results in a dissociative effect, whereas 
doses of 5-10 mg/kg result in an anaesthetic effect. Perceptual and mood changes 
in ketamine's non-medical use are highly dependent on age, dose, administration 
route and previous experience [Curran and Morgan 2000]. A lower dose usually 
produces a stimulant effect, whereas a higher dose produces psychedelic effects 
and diminishes the effects of the environment [Oye et al. 1992]. 
Ketamine misuse began in the 1970s in North America [Wolff and 
Winstock 2006], reaching its peak around 2000 in the US and then gradually 
decreasing in the drug abuse population. In 2002, 2.6% of high school seniors in 
the US reported ketamine use in the past year, with the percentage falling to 1.7% 
in 2009 [National Institute on Drug Abuse 2010]. The trends in Hong Kong differ 
considerably from those in the US. According to the Narcotics Division of Hong 
Kong's Central Registry of Drug Abuse, ketamine abuse began only after 2000. It 
then increased rapidly to reach a peak in 2008, and has decreased slightly in the 
past several years. Today, ketamine is the most commonly abused drug in Hong 
Kong, particularly among youths. About 70% of ketamine abusers are under the 
age of 21. Binge and withdrawal symptoms have been reported in most 
recreational ketamine users [Critchlow 2006, Leshner 2001, Wolff and Winstock 
2006]. 
2 
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1.2 Effect profile of ketamine in the brain 
1.2.1 Glutamate system dysfunction underlying ketamine actions 
Ketamine has multiple binding sites in the brain, although its binding affinity 
with the NMDAR is the highest. The drug's NMDA antagonistic effect is 
described in more detail in this section. The NMDA glutamate receptor plays an 
important role in excitatory neurotransmission. When a cell is in the resting state, 
postsynaptic NMDAR is blocked by magnesium ions. Presynaptic stimulations 
lead to the release of glutamates in the cleft, and these glutamates bind with 
another kind of glutamate receptor, 
a-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid, which causes 
depolarisation of the postsynaptic membrane. If the depolarisation reaches a 
threshold, magnesium ions withdraw from the NMDAR, making it available for 
glutamate binding. Upon binding with glutamate, the activated NMDAR opens its 
calcium channel, allowing a substantial number of calcium ions to enter the 
postsynaptic membrane rapidly, thereby inducing long-term potentiation (LTP) in 
the postsynapse. Entry of the calcium ions subsequently triggers a series of 
calcium-related cascade biochemical reactions, including protein synthesis and 
gene expression, which further maintains and amplifies the stimulation from the 
presynaptic cell and increases the synapse between cells. The induction and 
expression of LTP is also called synapse plasticity, which is important in memory 
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formation and consolidation. NMDAR dysfunction in the hippocampus via an 
antagonist such as ketamine or gene mutation has been shown to impair spatial 
learning in rodents [Bast et al. 2005, Parada-Turska and Turski 1990]. Encoding, 
but not retrieval, was impaired in these experiments. 
Glutamate acts in the brain not only as an excitatory agent but also as a 
regulator. NMDARs are also located in the gamma-aminobutyric acid (GABA), 
serotonergic and noradrenergic neurons. Activation of the NMDARs located in 
these neurons regulates the release of neurotransmitters in an inhibitory manner 
relative to the excitatory effect of the glutamate. It is the diminishment of the 
inhibition network that allows the NMDAR antagonist to increase the glutamate 
level and that of other excitatory amino acids, such as acetylcholine and aspartate, 
in the brain, and this effect can be blocked by a GABA agonist [Kim et al. 1999, 
Olney et al. 1999, Liu and Moghaddam 1995]. Increased glutamate can further 
lead to the release of other neurotransmitters via a non-NMDAR. In rats, one dose 
of subanaesthetic ketamine causes an increased glutamine level in the prefrontal 
cortex (PFC) and an increased dopamine level in both the PFC and striatum, and 
pretreatment with a non-NMDAR antagonist can prevent this effect [Moghaddam 
et al. 1997]. 
Increased glutamate and other neurotransmitters are thought to underlie the 
subjective and cognitive effects of ketamine. In an animal study, an increased 
glutamine level was correlated with prefrontal function impairment-like behaviour 
(working memory) in rats [Moghaddam et al. 1997]. Consistent with that study, an 
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acute dose of ketamine was found to increase the glutamate level in the anterior 
cingulate cortex in healthy human volunteers, and this increased glutamate level 
was correlated with poor Stroop test (executive function) performance [Rowland et 
al. 2005]. Elevated glutamate levels or brain regional activity in the parietal and 
left sensorimotor cortex and the thalamus have also been correlated with 
symptoms of psychosis in healthy human volunteers [Bartha et al. 1997, Deakin et 
al. 2008, Vollenweider et al. 1997]. Excessive glutamate neurotransmission may 
impair the integrity of auditory and visuosensory processing in the cortex, thus 
causing confusion and psychotic symptoms [Suzuki et al. 2000]. In addition, 
elevated dopamine after ketamine administration may explain the drug's 
addictiveness [Ross and Peselow 2009], although this elevation effect is weak and 
requires further investigation [Adams et al. 2002, Rabiner 2007]. 
5 
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1.2.2 Different effect patterns between acute and repeated administration 
Because acute ketamine administration has consistently been found to lead to 
psychotic symptoms and cognitive deficiency, researchers are also interested in 
determining the effects of repeated ketamine administration and the chronicity of 
these effects. 
Both acute and repeated doses of ketamine have been shown to result in 
unregulated NMDAR binding in rat hippocampus, but 2 weeks after the cessation 
of repeated treatment the NMDAR binding had decreased, thus indicating a lasting 
effect on NMDAR hypofunction status [Newell et al. 2007]. Different from acute 
administration, animals that repeatedly intake an NMDAR blocker have been 
found to exhibit decreased glutamate levels, decreased dopaminergic function, 
decreased glucose utilisation, and increased serotonin 2A receptor activity in the 
prefrontal or other brain regions [Mouri et al. 2007]. Persistent hypo-NMDAR 
function and a high glutamate level initiate a glial glutamate transporter increase, 
disturbance in the balance between the serotoninergic and dopaminergic systems, 
GABA interneuron dysfunction [Kittelberger et al. 2012] and calmodulin kinase II 
(CaMKII) signal pathway abnormality [Murai et al. 2007], all of which help to 
form the effects profile of repeated ketamine consumption. Data from 
micromorphological studies also suggest neuron degeneration across brain regions 
in rats continuously treated with PCP [Mouri et al. 2007]. In animal behaviour 
studies, acute-dose ketamine has been shown to cause hyperactivities that mimic 
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the positive psychotic symptoms of schizophrenia, whereas persistent ketamine use 
can further cause such negative symptom-like behaviour as increased immobility 
in maze tasks [Chatterjee et al. 2011]. Such negative symptom-like behaviour has 
also been related to disturbance in the balance between the serotoninergic and 
dopaminergic functions [Chatterjee et al. 2011]. Moreover, the acute effects of 
ketamine or PCP last around an hour, whereas repeated treatment may result in 
those effects lasting for weeks [Chatterjee et al. 2011, Mouri et al. 2007]. 
In human studies, chronic ketamine use has also been found to cause different 
and more permanent alterations in the brain that are distinct from those observed in 
laboratory studies. In contrast to the increasing effect of acute ketamine, 
dopamingergic function has been found to decrease in the dorsal PFC of 
recreational ketamine abusers [Narendran et al. 2005]. Reduced dorsal prefrontal 
grey matter volume and altered functional [Liao et al. 2012] and anatomical 
connectivity [Liao et al. 2010] in the prefrontal regions have also been reported in 
chronic ketamine abusers. In addition to these neurobiological findings, clinical 
studies provide similar results, showing dissociative and schizotypal symptoms 
and semantic memory impairment after one acute dose of ketamine prolonged to 
the third day after drug free in chronic users, whileas no such persistent effects 
were found in healthy volunteers [Curran and Morgan 2000]. In a similar study, 
one acute dose of ketamine resulted in more dissociative symptoms in chronic 
users than healthy volunteers, although no impairments were sustained into the 
third day [Uhlhaas et al. 2007]. 
7 
CHAPTER 1 BACKGROUND 1.2 Effect profile of ketamine in the brain 
Another important issue related to repeated ketamine use in human is the 
reversibility of its harmful effects, the timing of such reversibility and the extent to 
which it takes place. One group of ketamine abstainers who had not taken the drug 
in a month still had, on average, higher scores on a delusion scale than non-drug 
users [Morgan et al. 2009, 2010]. However, there is evidence demonstrating the 
reversibility of cognitive impairment after the cessation of chronic ketamine use, 
which is discussed in the next section. 
1.2.3 Acute and chronic effects of ketamine on human cognitive functions 
Researchers have proved in human studies that one-off doses of ketamine lead 
to temporary memory impairment in healthy volunteers, including working 
memory (N-back test) [Krystal et al. 2005, Morgan et al. 2004a] and episodic 
memory impairment [Morgan et al. 2004a, 2004b, Parwani et al. 2005, Rowland et 
al. 2005]. Ketamine has consistently been found to impair the process of encoding 
information in word list recall and recognition [Hetem et al. 2000, Rowland et al. 
2005], spatial learning [Rowland et al. 2005], prose recall [Morgan et al. 2004b] 
and the Hopkins Verbal Learning Test [Krystal et al. 2005], but not in the retrieval 
of information [Rowland et al. 2005]. Impairment of the early consolidation of 
information has also been observed [Parwani et al. 2005]. In tests examining 
ketamine's effects on executive functioning, performance was found to be intact in 
the Stroop colour-word interference task [Parwani et al. 2005], Trail Making A/B 
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test [Morgan et al. 2004a] and fluency test [Morgan et al. 2004b, Rowland et al. 
2005], whereas response inhibition was observed in the Hayling test [Morgan et al. 
2004b], and rule learning and shifting in the Wisconsin Card Sorting Test (WCST) 
was impaired [Krystal et al. 1999, 2000]. Moreover, acute ketamine use was 
shown to have a residual effect in frequent ketamine users [Curran and Monaghan 
2001], but none in healthy volunteers [Morgan et al. 2004b] or infrequent ketamine 
users [Curran and Monaghan 2001]. 
Because of ethical concerns, research on the chronic effects of ketamine 
use in humans is limited. Most existing studies focus on recreational ketamine 
users, in which semantic and episodic memory impairment has been observed 3 
days after a ketamine dose [Curran and Monaghan 2001, Morgan et al. 2004], 
whereas no such impairment was displayed by healthy volunteers [Morgan et al. 
2004b]. In one study, 18 recreational ketamine users were retested 3-4 years after 
recruitment. Semantic memory improved in line with decreased ketamine use, 
whereas episodic memory and attention remained deficient [Morgan et al. 2004]. 
Recent evidence shows frequent ketamine users (more than 4 times a week) to 
exhibit impairment in spatial working memory, pattern recognition, the Stockings 
of Cambridge task (planning) and category fluency compared with infrequent users, 
ex-users (abstinent for at least one month), normal controls and poly-drug users 
(other than ketamine) [Morgan et al. 2009]. Retrieval from source memory, prose 
recall (episodic memory), verbal fluency, and response initiation and inhibition 
(the Hayling test) were preserved in the frequent ketamine group in this study, 
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although no difference was found between ex- and infrequent ketamine users 
relative to non-drug users [Morgan et al. 2009]. A correlation has been found 
between the frequency of ketamine use and pattern recognition and working 
memory performance in frequent ketamine users [Morgan et al. 2010]. However, 
the chronic effects of ketamine are thought to be reversible, as Morgan et al. [2010] 
found ex-ketamine users and non-drug users to exhibit similar performance on 
these tasks. A local study [Chen et al. 2005] failed to detect any cognitive 
dysfunction in ketamine users. 
In summary, there is robust evidence to confirm that acute ketamine use 
causes impairment in episodic and semantic memory and some components of 
executive function. However, the evidence on the effects of chronic ketamine use 
is less robust, and there are also a number of flaws in the aforementioned studies. 
For example, they all had a small sample size. Moreover, in the studies carried out 
by Morgan et al., all of the ketamine users co-abused other drugs such as cocaine 
or cannabis, which may have confounded the effects profile of ketamine. 
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1.2.4 Sex differences in addiction 
Sex-specific patterns have been well documented across drugs, with females 
found more susceptible to drug abuse and relapse than males [Fattore et al. 2009, 
Lynch 2006]. Both local and Western studies have consistently reported female 
drug users to have greater morbidity and to be more likely to ‘self-medicate' than 
their male counterparts [Dluzen and Liu 2008, Laidler et al. 2004, Narcotics 
Division Security Bureau 2012]. Ovarian hormones mediate such sex-differences. 
For example, oestrogen has been shown to enhance stimulant-related 
dopamine release in the ‘reward' pathway [Walker et al. 2006] and GABA neuron 
inhibition in the striatum [Mermelstein et al. 1996] and to elevate cocaine- and 
stress-induced hypothalamic-pituitary-adrenal activation [Niyomchai et al. 2005]. 
It is thus clear that this hormone plays an important role in the initiation, 
maintenance and relapse of drug use in females [Carroll and Anker 2010, Lynch 
2006]. In animal studies, female rhesus monkeys have been shown to engage in 
more PCP self-administration than males [Carroll et al. 2005], and female rats to 
be more sensitive to the neurotoxic effects of ketamine than males 
[Jevtovic-Todorovic et al. 2001]. Research has also revealed multiple learning- and 
memory-associated neurological distinctions between the sexes [Andreano and 
Cahill 2009]. In general, men outperform women in special spatial skills, and 
women outperform men in functions related to episodic memory and semantic 
strategies [Andreano and Cahill 2009]. It has been suggested that the natural 
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differences in learning and memory between the sexes may also alter the effect of 
drugs on the cognitive functions of each [Morgan et al. 2006]. However, few 
studies in this arena have been carried out on humans. 
In two studies, healthy male and female volunteers displayed equal subjective 
effects [Krystal et al. 1998, Morgan et al. 2006] and cognitive consequences 
[Krystal et al. 1998] following ketamine intake, although the later study reported a 
sex difference in functional consequences. The male volunteers in that study 
recalled fewer words than the females in a word learning test taken after using 
ketamine [Morgan et al. 2006]. However, there is very little research on the 
differences between the sexes in terms of the functional consequences of drug use. 
The relationship between long-term ecstasy consumption and design fluency is 
reported to differ between men and women [Medina et al. 2005], and cocaine or 
amphetamine addiction appears to lead to more impaired decision-making in the 
latter [van der Plas et al. 2009]. One study of recreational cocaine users reported 
men to have poorer attention than women following short-term abstinence 
[Rahman and Clarke 2005]. Determining whether female drug users are more 
susceptible to cognitive impairment than males is of significant interest, as 
cognitive deficiency is thought to be related to treatment retention and outcome 
[Sofuoglu et al. 2013]. The study reported herein explored the sex-specific effects 
of ketamine use on cognitive function. 
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1.3 Introduction to cognition and intelligence and their 
assessments 
Cognition describes the acquisition, storage, transformation and use of 
knowledge. It includes a wide range of mental processes, such as perception, 
memory and problem-solving [Matlin 2005]. The definition of intelligence is less 
consistent, and it can be interpreted from different angles using different theories 
[Cianciolo and Sternberg 2004]. This section introduces the main component of 
cognitive processing, intelligence, and discusses the related measurements of each 
in relation to the current study. 
1.3.1 Memory and memory assessments 
'Memory refers to the persistence of learning in a state that can be revealed 
at a later time', according to Squire [1987, p. 3]. In a widely accepted theory, 
memory consists of short-term memory (later called working memory) and 
long-term memory. Short-term memory stores information temporarily, and 
long-term memory is more stable and permanent. Long-term memory can be 
further classified as procedural and declarative memory. Procedural memory refers 
to memory of how to do things considered to be automatic, for example, riding a 
bicycle, whereas declarative memory is the ability to store and retrieve facts or 
knowledge [Schwartz 2011]. Declarative memory is further divided into semantic 
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and episodic memory. Semantic memory is memory for general facts and concepts, 
and episodic memory for the storage of situation- and context-specific information 
[The Psychological Corporation 2002]. Knowledge and awareness of one's own 
memory regulation is called metamemory [Schwartz 2011]. Encoding, retrieval 
and autobiographical memory are the essential elements of long-term memory. 
Encoding refers to the initial acquisition of information, and retrieval means 
locating information in storage and accessing to it. Autobiographical memory is 
memory of an event related to oneself and one's daily life [Matlin 2005]. 
Existing memory tests focus primarily on testing episodic memory [The 
Psychological corporation 2002] and the encoding/retrieval of memories. Recall 
and recognition are common tasks in memory tests [Matlin 2005]. Source 
judgments about where and from whom we learned something constitute a direct 
test of episodic memory [Schwartz 2011]. Memory can also be divided into 
implicit and explicit memory. Implicit memory is memory at the unconscious level, 
whereas explicit memory is conscious. In a test condition, a subject will not realise 
that his or her implicit memory is being tested, whereas in tests of explicit memory 
subjects are conscious of what they are being asked to remember and later recall. 
To sum up, the memory test battery encompasses recall, recognition, implicit 
memory tests, source judgments and metamemory judgments [Schwartz 2011]. 
The Wechsler Memory Scale developed by Wechsler in 1945 is an 
individually administered clinical instrument that assesses components of memory 
and learning in older adolescents and adults. The Wechsler Memory Scale-Third 
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Edition (WMS-III) includes 6 primary subtests (logical memory, letter-number 
sequencing, verbal paired associates, faces, family pictures and spatial span) and 5 
optional subtests (word list, mental control, digit span, visual reproduction, and 
information and orientation). Primary index scores, including 3 global composite 
indexes (immediate memory index, general memory index and working memory 
index) and 5 additional index scores (auditory immediate, visual immediate, 
auditory delayed, visual delayed and auditory recognition delayed), are calculated 
from the core subtests [The Psychological Corporation 2002]. This construction of 
composites and indexes is based on theoretic principles and factor structure 
analysis of the previous version. Research on the previous version consistently 
verified a three-factor model comprising working memory, immediate memory 
and delayed memory [The Psychological Corporation 2002], with the latter two 
corresponding theoretically to the encoding and retention of memories [Tulsky 
2004]. However, factor analysis of the WMS-III otherwise supports another 
three-factor model: working memory, auditory memory and visual memory. Some 
researchers also encourage the continued use of the immediate and delayed 
indexes in clinical studies for clinical and theoretic considerations [The 
Psychological Corporation 2002, Tulsky et al. 2004]. 
Working memory is immediate memory for material that is currently being 
processed. It is an active form of short-term memory in which calculation and 
manipulation occur. Compared with long-term memory, working memory is 
limited in its information storage capacity [Matlin 2005]. The basic design of an 
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experiment testing working memory is to present a large amount of information to 
examinees and ask them to retain it. The difficulty of a working memory task can 
be increased in two ways: expanding the amount of material during a single task or 
limiting the availability of attention capacity by asking subjects to perform two 
tasks simultaneously. These dimensions are closely related, with no practical 
difference between them. Digit span is widely used as a measure of working 
memory. The forward digit span mode (Digit Span Forward [DSF]) measures the 
storage component of working memory, whereas, in the backward mode (Digit 
Span Backward [DSB]), task complexity is increased by deemphasising the 
manipulation of the material by reordering the presented digits [The Psychological 
Corporation 2002]. 
1.3.2 Executive function and assessments of executive function 
Baddeley and Hitch [1974] first described the 'central executive' in their 
model of working memory, describing it as a supervisory system that controls and 
adjusts two subsystems, namely, the phonological loop and the visuospatial 
sketchpad. The single unit property of executive function was refined by Lezak 
[1995], who also defined executive function as the integration of initiation, 
planning, purposive action, self-monitoring, self-regulation and volition. The 
components of inhibition and shifting have also been well defined in executive 
function research [Stuss 2011]. Later theories have generally posited executive 
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function as the collaboration of several abilities that allow us to shift our minds to 
adapt to new situations and inhibit inappropriate responses, initiate and maintain a 
goal, and create and execute a plan [Jurado and Rosselli 2007]. The Stroop test, 
WCST and verbal fluency (VF) test are the most widely used measures of 
executive function [Alvarez and Emory 2006]. 
Stroop test 
The Stroop test [Stroop 1935] consists of 300 items and is divided into 3 
types of stimuli: neutral colour naming, neutral word reading and incongruent 
colour-word naming. The raw score, which is presented as reaction speed, is 
calculated by the number of correct responses in each stimuli type in 45 seconds. 
In the incongruent colour-word naming task, participants generally respond 
relatively slowly, give fewer total responses and make more errors than in the 
other 2 conditions because of the contradiction between colour naming and word 
reading [Golden 1976, Stroop 1935]. Some researchers have made modifications 
to the Stroop test, but retained the 3 different types of stimuli (e.g. colour dot 
naming [Part D], neutral colour words [Part W] and incongruent colour words 
[Part C]) [Lezak 1995, Perret 1974, Regard 1981], and it has been translated into 
Chinese [Lee and Chan 2000]. Each condition includes 24 items. Subjects are 
required to read the given colour of the dots in Part D, the colour of the unrelated 
words in Part W and the printed colour of the incongruent colour word in Part C, 
and the number of errors and reaction time are recorded for each condition. 
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Subjects generally take longer and make more errors in Part C because of 
activation of the inhibitory process or interference effect. The additional time spent 
on Part C is considered to be time spent on inhibiting word reading or resolving 
interference [Ludwig et al. 2010], whereas the increased error rate is seen as an 
index of the temporal maintenance of the task goal [Kane and Engle 2003]. 
Wisconsin Card Sorting Test 
The WCST was first developed by Esther Berg [Eling et al. 2008] in 1948 
to test ‘shifting', which involves learning a rule and then switching to another rule. 
Milner [1963] was the first to use the WCST to examine functioning following 
frontal lobe injury, and it has since been popularly used to evaluate frontal lobe 
function or executive function in a variety of populations [Nyhus and Barcelo 
2009]. The main purpose of the WCST is to test abstract reasoning, concept 
formation and response strategies to changing conditions [Eling et al. 2008]. The 
original and full version of the WCST comprises four stimulus cards and 128 
response cards. Participants are asked to match each response card with a stimulus 
card in each trial according to the examiner's ‘right' or ‘wrong' feedback. More 
details of this test are provided in the Methods section. Although 16 index scores 
are available in the WCST, performance can be reflected by just 2 or 3 index 
scores with integrity and a strong correlation among outcome measures [Nyhus 
and Barcelo 2009]. 
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Verbal fluency 
VF is another frequently used test in executive function assessment [Henry 
and Crawford 2004]. VF tests take two common forms: semantic (or category) VF 
and phonemic (or letter) VF. Both are widely used to assess executive function in a 
variety of populations. Semantic/category VF involves the use of semantic 
memory to produce as many words as possible within a given category [Henry and 
Crawford 2004]. Lexical representation, the organisation of verbal retrieval and 
recall, self-monitoring, and response inhibition are essential cognitive components 
in phonemic VF, which requires participants to produce words that begin with a 
given letter. In clinical and functional magnetic resonance imaging (fMRI) studies, 
phonemic VF is more likely to be associated with the frontal lobe, whereas the 
temporal lobe is more likely to contribute to semantic VF. A number of studies 
have documented an association between phonemic VF and neurological factors, 
although this association could be confounded by verbal intelligence [Henry and 
Crawford 2004]. Furthermore, owing to the distinct linguistic properties of the 
Chinese language [Chan et al. 2003, Chiu et al. 1997], most studies in Chinese 
populations use semantic VF. A modified Chinese semantic VF test that has been 
validated in the local population [Chan 2004] was used in this study. 
1.3.3 Intelligence and intelligence tests 
Intelligence 
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The definition of intelligence has been debated since the time of the ancient 
Greeks. Spearman [1927] was the first to discuss it as a psychological concept. He 
believed that individual differences in intelligence are primarily attributable to a 
general factor, g, and specific factors, s, that play an important role in g. Thurstone 
[1938] and Guilford [1956] argued against the idea of a general factor (g), 
although Thomson [1939] extended the nature of such a factor. Research supports 
a multiple-factor intelligence structure, and a number of models of intelligence 
have been proposed over the years. Among the most influential are Cattell and 
Horn's theory of fluid and crystallised intelligence and Carroll's three-stratum 
theory [Kamphaus et al. 2005]. 
Cattell developed the fluid-crystallised theory of intelligence in 1941, 
which posited fluid and crystallised intelligence as two distinct general factors, 
following factor analysis of existing intelligence tests. Horn further expanded the 
theory with 9 general ability factors in the 1990s [Wasserman and Tulsky 2005], 
and it is now known as the Cattell-Horn theory of fluid and crystallised 
intelligence. Carroll [2005] subsequently published his three-stratum theory in 
1993 after reviewing and reanalysing 460 sets of data that included all of the 
important factor-analytic studies of human intelligence available at that time. In 
this hierarchical theory, stratum III ability is the highest level ability, known as g, 
whereas stratum II ability contains 8 broad abilities, and stratum I numerous 
narrow abilities. Compared with the Cattell-Horn theory, Carroll's theory expands 
general abilities (stratum II) to lower narrow abilities (stratum I) and also to a 
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higher level (g) [Carroll 2005]. There are no differences between the two in the 
classification of broad abilities [McGrew 2005]. McGrew and Flanagan [1998] 
later integrated the two theories into the Cattell-Horn-Carroll (CHC) theory. 
The nature of intelligence cannot be fully explained by the aforementioned 
structured models, and thus complex models of intelligence taking other aspects into 
account have been constructed. For instance, Naglieri et al. [2005] developed a 
model of brain function and its structure that conceptualised the cognitive function 
within the framework of three brain units: project area, associated area and 
overlapping area. These units provide four basic cognitive processes that are related 
to performance rather than the verbal-nonverbal model. Gardner [1983/1993] 
identified 7 distinct domains of intelligence in his original theory of multiple 
intelligences. He also placed emphasis on the interaction between the components 
that contribute to these domains and that between biological predisposition and the 
environmental and cultural context. These domains of intelligence can be interpreted 
in conventional and unconventional ways. Conventional interpretations include the 
linguistic, logical-mathematical and spatial, whereas unconventional interpretations 
include the musical, body-kinaesthetic, interpersonal and intrapersonal. Gardner and 
his colleagues subsequently developed the Project Spectrum Preschool Assessment 
Activities, which measure performance in 7 areas, movement, language, 
mathematics, social skills, music, visual arts, and science, to provide an intellectual 
profile of the examinee [Chen et al. 2005a]. Sternberg's [2005] triarchic theory 
distinguishes three aspects of intelligence: the componential, experiential and 
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contextual. Individuals succeed intellectually by recognising their strengths and 
weaknesses when dealing with environmental changes, although finding a balance 
among the three aspects of intelligence is key. These theories were formulated 
primarily to provide guidance to educators [Chen and Gardner 2005, Naglieri and 
Das 2005, Sternberg 2005], although Sternberg [2005] later proposed a broader 
conception of ‘successful intelligence' that posits intelligence as a balance of the 
analytical, creative and practical components of intelligence. 
Given the slow progress in exploring the nature of intelligence, it is not 
surprising that consensus is far from being achieved on a definition [Wasserman 
and Tulsky 2005]. Wechsler [1939, p. 3] defined intelligence as ‘the aggregate or 
global capacity to act purposefully, to think rationally, and to deal effectively with 
[one's] environment'. He believed intelligence to be a global function but to 
comprise elements or abilities that are qualitatively different. His conception is 
thus representative of structured theories of intelligence. In his later career, 
Wechsler realised that non-intellective factors such as personality traits, 
motivations and attitudes also contribute to performance in intelligence, as well as 
in effectiveness in daily living skills and in meeting everyday challenges [The 
Psychological Corporation 2002]. 
Intelligence tests 
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The measurement of intelligence is generally accompanied by or based on 
theories of intelligence. Examples include the Kaufman Adolescent and Adult 
Intelligence Test (KAIT) [Kaufman and Kaufman 1993], Woodcock-Johnson III 
Test of Cognitive Abilities (WJ-III) [McGrew and Woodcock 2001], and the 
Wechsler Intelligence Scales and Stanford-Binet Intelligence Scales, Fifth Edition 
(SB5) [Roid 2003]. Several intelligence batteries have been developed for 
application to adults. 
Sir Francis Galton first assessed intelligence in the late 19th century, and 
McKeen Cattell later expanded his work in the United States. The original test 
focuses on simple psychological processes, for instance, speed of movement and 
sensory capability, but shows poor internal correlation and concurrent validity with 
more complex measures of intellectual performance such as university marks 
[Cianciolo and Sternberg 2004]. Alfred Binet's work is considered to constitute the 
beginning of modern intelligence testing [Wasserman and Tulsky 2005]. In 1916, 
he and Theodore Simon proposed a series of tests that relied on a higher level of 
cognition function and well-developed judgment skills such as verbal skills and 
social comprehension. They arranged a series of tasks of increasing difficulty to 
measure the intelligence level of different age groups. Consequently, the concept 
of mental age was introduced, that is, the age level at which a child can 
successfully perform in an intellectual way. The Binet-Simon scale had better 
practical utility than the earlier measure, and was subsequently revised into several 
versions. The most notable revision was made by Lewis Terman in 1916. This 
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revision came to be known as the Stanford-Binet Intelligence Scales, and was the 
first to introduce the concept of the intelligence quotient (IQ) [Cianciolo and 
Sternberg 2004]. The SB5, which was launched in 2003, contains 5 verbal subtests 
and 5 non-verbal subtests. It provides a global IQ score and 5 factor index scores: 
fluid reasoning, quantitative reasoning, general knowledge, visual-spatial abilities 
and working memory. This revision benefited both from the Rasch analysis used in 
scale design and development and the modification of the sensitivity score to allow 
cognitive change to be tracked over time [Roid and Pomplun 2005]. The 
Stanford-Binet Intelligence Scales were the most widely used intelligence measure 
in the first half of the 20th century but were later supplanted by the Wechsler 
intelligence scale [Wasserman and Tulsky 2005]. 
The Wechsler-Bellevue Intelligence Scale, developed by David Wechsler 
in 1939, is another major contemporary test. This scale incorporates both verbal 
and performance index scores in addition to an overall score. In the decades since 
its introduction, the scale has undergone several modifications of its norms, items 
and score rules [The Psychological Corporation 2002]. The series of scales 
developed by Wechsler include the Wechsler Preschool and Primary Scale of 
Intelligence for preschool and primary school pupils, the Wechsler Intelligence 
Scale for Children for children between the ages of 6 and 16, and the Wechsler 
Adult Intelligence Scale (WAIS) for adults and older adolescents. Wechsler's 
scales are notable because they combine verbal and performance tests into a single 
battery, align psychological assessment and clinical practice, and introduce the 
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‘deviation IQ', which measures how one individual's performance deviates from 
that of others of the same age group [Wasserman and Tulsky 2005]. The WAIS-III 
produces 3 primary index scores, a full-scale index score, verbal intelligence index 
score and performance intelligence index score. In addition to these scores, another 
four more discrete cognitive index scores are supported by factor analysis: verbal 
comprehension, perceptual organisation, working memory and processing speed 
scores. Table 1 presents the subtests that contribute to these four composite scores. 
A number of short forms of the WAIS-III have been developed to overcome the 
administrative demands of the full scale [Axelrod 2001], particularly in clinical 
samples. The short forms vary in their number of subtests. Examples include the 
3-subtest model [Chan et al. 2005], the Wechsler Abbreviated Scale of Intelligence, 
which contains 4 subtests extracted from the first two index factors [The 
Psychological Corporation 1999], a 4-subtest model extracted from each of the 4 
index factors in the WAIS-III [Blyler et al. 2000], a 7-subtest model [Axelrod et al. 
2001] and an 8-subtest model that generates a general ability index [Tulsky et al. 
2001]. 
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Table 1 Subtests grouped according to the WAIS-III factor structure 
Verbal comprehension Perceptual 
organisation 
Working memory Processing speed 
Vocabulary Block Design Digit Span Digit Symbol-Coding 
Similarity Matrix Reasoning Arithmetic Symbol Searching 
Information Object Assembly Letter-Number Sequencing 
Picture Completion 
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KAIT and the WJ-III are derived from CHC theory. The former produces 2 
composite scores, a crystallised scale score and a fluid scale score, and includes a 
6-subtest core battery and 10-subtest expanded battery [Kaufman et al. 2005]. The 
WJ-III comprises 31 subtests, and can be divided into the WJ-III Test of Cognitive 
Ability (WJ-III COG) (20 subtests) and WJ-III Diagnostic Supplement to the 
WJ-III COG (11 subtests). Performance on the WJ-III is interpreted on 4 levels. 
The first level is narrow abilities, namely, the single subtest-related abilities. The 
second level measures broad abilities, which contain 7 clusters. The third names 
cognitive category clusters and contains 3 clusters, and the fourth represents 
general intellectual ability. The most notable properties of the WJ-III are its rich 
concrete subtests and the proficiency statement component of the results report, 
which is also based on Rasch analysis [Schrank 2005]. The Reynolds Intellectual 
Assessment Scales (RIAS) and Reynolds Intellectual Screening Test (RIST) are 
also based on CHC theory. RIAS includes a 2-subtest Verbal Intelligence Index 
and 2-subtest Nonverbal Intelligence Index and a global intelligence indicator, the 
Composite Intelligence Index. RIAS also includes 2 subtests for memory testing, 
and thus produces a Composite Memory Index. RIST contains 2 subtests and can 
be completed in 10 minutes. Its aim is to screen for the need to carry out a 
full-scale RIAS assessment. RIAS has been widely used in childhood 
psychopathology and in neurological diseases (for example, dementia and brain 
injury), and may thus demonstrate efficacy in combination with measures of the 
examinee's intelligence information [Reynolds and Kamphaus 2005]. Although 
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the aforementioned tests are well known and widely used, the WAIS-III remains 
the gold standard [Umphress 2008] and is the most frequently used in adult 
populations [Rabin et al. 2005]. 
1.4 Study hypotheses 
To sum up, there is substantial evidence to show the acute effect of 
ketamine on human memory in ketamine-nai've volunteers, but the long-term 
outcome profile of this effect is unclear. The study reported in this thesis was thus 
carried out to evaluate the long-term effects of ketamine use on both cognitive 
function and psychological well-being in Hong Kong youths. It tested the 
following hypotheses. (a) Memory is significantly impaired in both primarily 
ketamine (Primarily K) and poly-drug ketamine (Poly K) users. (b) Drug use 
severity is a risk factor in cognitive impairment. (c) Psychiatric problems are 
notable in ketamine users. (d) Poly K users suffer more severe impairment in 
cognitive and psychological function than Primarily K users. (e) The cognitive 
impairment caused by ketamine is reversible. (f) Female users suffer greater 
cognitive impairment than their male counterparts. 
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CHAPTER 2 METHODS 
2.1 Study design 
This study was cross-sectional in design. Participants were recruited 
according to their drug abuse patterns, and assigned to a primarily ketamine abuse 
(Primarily K) group, ketamine and other psychotropic drug abuse, or poly-drug 
ketamine abuse (Poly K), group, and a healthy control (HC) group. The groups 
were compared in terms of cognitive function, with such common confounding 
factors as education level, psychiatric comorbidities and drug use severity taken 
into consideration. The study procedure is illustrated in Figure 1. All participants 
were given a $150 coupon as compensation for attending the basic assessment and 
another $250 coupon for attending a psychiatric interview if deemed necessary. 
The study was approved by the Survey and Behavioural Research Ethic 
Committee of the Chinese University of Hong Kong 
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Figure 1 Study procedure 
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2.2 Study subjects 
2.2.1 Subject recruitment sites 
Participants were recruited from non-governmental organisations (NGOs) 
in Hong Kong. The drug abusers were referred by the Counselling Centres for 
Psychotropic Substance Abusers, residential treatment centres and district youth 
outreaching teams, whereas the HCs were recruited from community service 
centres according to the study's inclusion criteria. The NGOs that provided 
referrals are the following. 
a. Jockey Club Ma On Shan (South) Children & Youth Integrated Services 
Centre, Hong Kong Sheng Kung Hui Welfare Council 
b. Yuen Long District Youth Outreaching Social Work Team, Hong Kong 
Christian Service 
c. Sha Tin Youth Outreaching Social Work Team, Chinese Young Men's 
Christian Association of Hong Kong 
d. Hong Kong North District Hospital UROK Clinic 
e. Evergreen Lutheran Centre, Hong Kong Lutheran Social Services 
f. Rainbow Lutheran Centre. Hong Kong Lutheran Social Services 
g. Cheer Lutheran Centre, Hong Kong Lutheran Social Services; 
h. Hong Kong Christian Service PS33-Tsimshatsui Centre; 
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i. Hong Kong Christian Service PS33-Shamshuipo Centre 
j. Hong Kong Sheng Kung Hui Welfare Council Neo-Horizon 
k. Caritas HUGS Centre 
l. Caritas Lok Heep Club 
m. Jockey Club Wah Ming Lutheran Integrated Service Centre, Hong Kong 
Lutheran Social Services 
n. Jockey Club Yung Shing Lutheran Integrated Service Centre, Hong Kong 
Lutheran Social Services 
o. Christian New Life Association 
p. Operation Dawn 
q. Society for the Aid and Rehabilitation of Drug Abusers 
2.2.2 Inclusion criteria 
a. Aged between 16 and 30 
b. Capable of giving informed consent 
c. Receiving services at an NGO 
d. For the Primarily K group: use of ketamine at least 24 times over 6 months 
within the past 2 years and use of other illicit psychotropic drug(s) fewer than 
24 times over 6 months within the past 2 years 
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e. For the Poly K group: use of ketamine together with other illicit psychotropic 
drug(s) such as ecstasy, marijuana or methamphetamine at least 24 times over 
6 months within the past 2 years 
f. For the HC group, no history of substance abuse [Chen et al. 2005] 
g. No history of any neurological disorder, significant medical disease that 
requires regular medication or severe head injury 
2.3 Data collection 
2.3.1 Demographic information 
Two research assistants (RAs) collected demographic information from and 
performed all of the cognitive function assessments on the subjects at the NGOs. 
The demographic information collected included information on 
a. age, 
b. sex, 
c. years of education, 
d. marital status, 
e. employment status, 
f. monthly income, 
g. district of residence and 
h. housing status. 
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2.3.2 Drug use pattern and s^^^rity 
The Severity of Dependence Scale (SDS) [Gossop et al. 1995], a 5-item 
self-report scale, was administered to participants to measure their degree of drug 
dependence in the past month or in the month before abstinence. Each item received 
a score from 0 to 3, with a higher score indicating more severe dependence. 
The Addiction Severity Index (ASI)-Lite Version [ASI-Lite; Cacciola et al. 
2007] is a multi-dimensional index measuring substance use, health and social 
problems [McLellan et al. 2006]. It is a semi-structured scale that covers the medical, 
employment/support, drug and alcohol use, legal, family/social and psychiatric 
dimensions. ASI-Lite acquires information on these dimensions across the life span. 
In this study, a composite score was calculated for each area, with a higher score 
indicating more severe problems in that area. Composite scores ranged from 0 to 1. 
A psychiatrist (Huanjun Liang) made a diagnosis of lifetime or current drug 
dependence according to the Diagnostic and Statistical Manual of Mental Disorders, 
Fourth Edition [DSM-IV; American Psychiatric Association 2000] criteria for 
substance dependence based on the information recorded by the RAs. 
2.3.3 Psychiatric comorbidities 
The 21-item version of the Beck Depression Inventory [BDI; Shek 1990] was 
used to screen for depressive disorder. The BDI was applied to a group of ecstasy 
users in Hong Kong in an earlier study [Chen et al. 2005]. The total BDI score 
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ranges from 0-63. A cut-off of 8/9 was used to screen out participants with potential 
depressive symptoms in this study. The sensitivity and specificity of this cut-off are 
100% and 82%, respectively [Lee et al. 2001]. 
The anxiety subscale of the Hospital Anxiety Depression Scale [HASDSA; 
Leung et al. 1993] was used to screen for anxiety disorders. HADSA has 7 items, 
each receiving a score from 0 to 3. A higher total score indicates more severe 
symptoms. The sensitivity of a cut-off of 4/5 is 96% [Bunevicius et al. 2007]. 
Psychosis screening questions derived from the Chinese version of the 
Structured Clinical Interview for DSM-IV [C-SCID; So et al. 2003a] were 
administered to screen for possible psychotic disorders. Subjects who scored 
positively on one or more items were referred to a psychiatrist for further diagnosis. 
To check inter-rater reliability, the two RAs performed psychosis screening on the 
same 20 subjects. The kappa was 1.0, which means they were highly consistent in 
their determination of whether a subject exhibited possibly psychotic symptoms. 
Subjects who scored positively on the BDI, HADSA or C-SCID psychotic 
symptoms screen were referred to a psychiatrist (Alan Tang) for a structured 
psychiatric interview based on C-SCID [So et al. 2003a, b]. This interview focused 
on diagnoses of mood disorders, anxiety disorders and psychotic disorders and 
would be arranged in one month. This interview was carried out in a meeting room 
in the Department of Psychiatry at Shatin Hospital or over the phone. Subjects with 
an active diagnosis will be referred to treatment. 
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2.3.4 Cognitive function evaluation 
The cognitive battery comprised the following domains and tests. 
a. General intelligence: the 3-subtest short form of the WAIS-III [Chan et al. 
2005]. 
b. Executive functioning: the Stroop test [Stroop 1935], Modified VF Test 
[MVFT; Chiu et al. 1997] and WCST [Heaton et al. 1993]. 
c. Attention and working memory: DSF and DSB [Wechsler 1997a]. 
d. Verbal memory: story recall: immediate recall, delayed recall and recognition 
[Hua et al. 2005, Wechsler 1997b]; word list recall: immediate recall, delayed 
recall and recognition [Hua et al. 2005, Wechsler 1997b]. 
e. Visual memory: the Rey-Osterrieth Complex Figure (ROCF) [Osterrieth 1944, 
Taylor 1959]. 
f. Language: Modified Boston Naming [Wechsler 1997a]. 
General intelligence was examined using the 3-subtest short form of the 
WAIS-III. As noted in the previous chapter, the full-scale WAIS-III, which 
includes 13 subscales, has been widely used internationally to evaluate intelligence, 
but it is time-consuming to administer. Hence, as also noted, a number of short 
forms have been developed over the years [Axelrod et al. 2001, Blyler et al. 2000]. 
The 3-subtest short-form WAIS-III used in the current study contains information, 
arithmetic and Digit-Symbol Coding (DSC) subtests, and has been tested in a local 
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healthy population [Chan et al. 2005]. The score ranges on the 3 subtests are 0-22, 
0-28 and 0-133, with higher scores meaning better performance. 
A simple version of the Stroop test [Lee and Chan 2000] was adopted in 
this study. Details are provided elsewhere in the thesis. The three index scores of 
Stroop test for executive function are the total number of errors and the total 
reaction time in part C, W and D, and the reaction time difference indexed between 
parts C and D. 
In the MVFT, participants were required to generate as many animal names 
as possible in 1 minute, as many fruit names as possible in 30 seconds and as many 
vegetable names as possible in another 30 seconds. The number of words, 
preservative errors and intrusive errors in each category were counted. A 
preservative error was counted as 1 when a word was produced repeatedly and an 
intrusive error as 1 when a word was not in the correct category. The total number 
of correct responses constituted the total MVFT score. 
The WCST involves 4 stimulus cards and a set of 64 response cards. All of 
the response cards differ in three dimensions: colour (red, green, yellow and blue), 
pattern (triangle, star, cross and circle) and number (one, two, three and four). 
Participants are required to work out a sorting principle to match each response 
card to the 4 stimulus cards (red triangle, two green stars, three yellow crosses or 
four blue circles) according to feedback from the examiner. Once a participant has 
made 10 consecutive correct matches according to the sorting principle, the 
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principle is changed without warning, and he or she has to develop a new sorting 
principle. The test is terminated in 2 circumstances: (1) when the participant 
successfully maintains 6 correct sorting principles (colour, pattern, number, colour, 
pattern, number) or (2) when he or she completes 128 trials. To evaluate a 
participant's abstract reasoning ability and ability to shift cognitive strategies, each 
response he or she makes is recorded for subsequent scoring. The subsequent 
scores, such as those for correct responses, preservative responses, preservative 
errors and non-preservative errors, are also recorded. The number of categories 
completed, total trials and number of preservative errors made up the index scores 
in this study. 
Digit Span, made up of DSF and DSB, is a standardised measure of 
attention and working memory. The forward and backward modes are administered 
separately. In the forward mode, participants are instructed to immediately repeat a 
string of 2-9 digits in the same order as that presented by the examiner. In the 
backward mode, they are instructed to immediately repeat a string of up to 8 digits 
in reverse order. Each mode begins with the 2-digit item, and the test is terminated 
when a participant fails to repeat the digit string correctly in both trials or 
completes all items. In this study, both the DSF and DSB sub-scores and a total 
score were recorded. The DSB requires more effort from working memory than the 
DSF, and is thus more effective in identifying working memory deficiency [Davis 
et al. 2003]. In this study, both DSF and DSB sub-score were selected as the index 
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o f w o r k i n g m e m o r y . It r a n g e s f r o m 0 - 1 6 a n d 0 - 1 4 , respectively, w i t h a h i g h e r 
score indicating better p e r f o r m a n c e . 
V e r b a l m e m o r y capacity w a s m e a s u r e d b y the w o r d list a n d logical 
m e m o r y subtests in W A I S - I I I . B o t h subtests include 3 elements, n a m e l y , 
i m m e d i a t e l y recall, d e l a y e d recall a n d recognition. In the w o r d list subtest, 
participants w e r e presented w i t h 2 w o r d lists (List A a n d List B ) separately, w i t h 
1 2 unrelated w o r d s o n e a c h list. T h e e x a m i n e r read o u t List A four times, a n d the 
participant w a s a s k e d to p e r f o r m free recall o f the w o r d s i m m e d i a t e l y after e a c h 
trial. T h e total n u m b e r o f w o r d s recalled in all f o u r trials for List A w a s t h e n 
calculated. T h e e x a m i n e r t h e n r e a d o u t List B o n c e , a n d a s k e d the participant to 
i m m e d i a t e l y recall the w o r d s therein in a n y order. Finally, the e x a m i n e r r e q u e s t e d 
that the participant recall the w o r d s f r o m List A w i t h o u t rereading it. A f t e r a 
3 0 - m i n u t e interval, the participant w a s t h e n a s k e d to recall List A a n d to state 
w h e t h e r t h e y r e c o g n i s e d the 1 2 w o r d s in List A f r o m a list o f 2 4 w o r d s b y 
r e s p o n d i n g 'yes' o r ‘no，. T h e n u m b e r o f correct recognitions w a s recorded. T h e 
n u m b e r o f correct r e s p o n s e s in i m m e d i a t e a n d d e l a y e d recall, the n u m b e r o f 
corrected recognitions a n d the retention rate (correct r e s p o n s e in d e l a y e d recall / 
correct r e s p o n s e in the 4
t h
 i m m e d i a t e recall) w e r e 4 o u t c o m e scores o f this task. 
In the logical m e m o r y subtest, the participants w e r e instructed to listen to 
a n d t h e n retell t w o stories, first i m m e d i a t e l y a n d t h e n a g a i n after a 3 0 - m i n u t e 
interval. T h e y w e r e a s k e d to recall Story B t w i c e in the i m m e d i a t e recall. T h e 
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e l e m e n t s in the retelling o f the stories w e r e divided into story units a n d thematic 
units. A story unit refers to story content a n d a thematic unit to a story t h e m e . 
Finally, the e x a m i n e r a s k e d 15 questions a b o u t the content o f e a c h story. T h e 
o u t c o m e scores included the total n u m b e r o f story units in the i m m e d i a t e recall o f 
Stories A a n d B , the total n u m b e r o f story units in the d e l a y e d recall o f the t w o 
stories a n d the total n u m b e r o f correct recognitions. T h e story unit retention score 
w a s calculated b y : ( i m m e d i a t e recall o f Story A 士 s e c o n d i m m e d i a t e recall o f Story 
B / ( d e l a y e d recall o f Story A 士 d e l a y e d recall o f Story B). 
V i s u a l construction a n d visual m e m o r y w e r e tested w i t h the R O C F , w h i c h 
m e a s u r e s the conditions o f c o p y , i m m e d i a t e recall, d e l a y e d recall a n d recognition. 
Participants w e r e instructed to c o p y a c o m p l e x figure that h a d b e e n presented to 
t h e m , a n d the figure w a s r e m o v e d f r o m sight o n c e their c o p y h a d b e e n c o m p l e t e d . 
T h r e e m i n u t e s ( i m m e d i a t e recall) a n d 3 0 m i n u t e s (delayed recall) later, the 
participants w e r e a s k e d to r e d r a w the figure w i t h o u t seeing it again. T h e test's 
score t o o k a c c o u n t o f the a c c u r a c y a n d p l a c e m e n t o f the figure's elements, 
a c c o r d i n g to a 36-point scoring s y s t e m [Taylor 1959]. After c o m p l e t i o n o f the 
d e l a y e d recall task, participants w e r e s h o w n 2 4 g e o m e t r i c i t e m s a n d a s k e d to 
recognise w h i c h o f t h e m h a d a p p e a r e d in the c o m p l e x figure that they h a d b e e n 
a s k e d to c o p y earlier. T h e n u m b e r o f correct recognitions (the s u m o f true positive 
a n d false negative items), scores o f i m m e d i a t e a n d delay recall a n d retention 
( i m m e d i a t e / delay recall) w e r e the i n d e x scores. 
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L a n g u a g e ability w a s evaluated b y the M o d i f i e d B o s t o n N a m i n g test, 
w h i c h requires participants to n a m e 15 c o m m o n objects s h o w n to t h e m in pictures. 
T h e total n u m b e r o f objects correctly n a m e d constitutes the i n d e x score. A 
s u m m a r y o f the cognitive tests a n d m a x i m u m scores is g i v e n in T a b l e 2. 
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T a b l e 2 Cognitive battery 




Executive function Stroop 
MVFT 
WCST 















Number of trials administered 
Categories completed 
Numbers of preservative ( 
Forward 
Backward 
Verbal memory Logical Memory/Story Logical Memory I 
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Telling 
Word List 
Visual memory ROCF 
Language 
Total Immediate Recall 
Logical Memory II 
Word List I 
Word List II 
Delayed Recall 
Recognition 










Recognition Total Correct 
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2.4 Statistical methods 
D a t a analyses w e r e p e r f o r m e d u s i n g S P S S 17.0. C o n t i n u o u s variables w e r e 
described as m e a n 士 S D , a n d categorical variables as N (%). A n a l y s i s o f variance 
( A N O V A ) w a s u s e d to c o m p a r e the c o n t i n u o u s variables a m o n g groups, a n d the 
chi-square test w a s u s e d to analyse categorical variables. T h e significance level 
w a s set as 0.05. M u l t i p l e c o m p a r i s o n s w e r e u s e d in the post h o c analyses, a n d the 
significance level w a s adjusted to 0.017. T h e correlation recorded b e t w e e n t w o 
c o n t i n u o u s variables w a s the P e a r s o n correlation. W h e n several subtest scores 
w e r e c o m b i n e d , standard transformation w a s p e r f o r m e d before c o m b i n a t i o n . 
Logistic regression w a s p e r f o r m e d to explore the i n d e p e n d e n t risk o f k e t a m i n e u s e 
a n d the pattern o f m e m o r y i m p a i r m e n t c a u s e d b y k e t a m i n e . A univariate general 
linear m o d e l ( G L M ) w a s u s e d to adjust s u c h c o n f o u n d e r s as age, sex, education 
a n d B D I score. Finally, t w o - w a y A N O V A w a s c o n d u c t e d to detect the effect o f 
factor interaction. 
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CHAPTER 3 RESULTS 
3.1 Demographics and basic information 
T w o h u n d r e d k e t a m i n e users a n d 1 0 0 H C s participated in the study. T h e Primarily 
K g r o u p w a s significantly older than b o t h the H C a n d P o l y K g r o u p s (p = 0.003 
a n d p = 0.001, respectively). T h e Primarily K a n d P o l y K g r o u p s h a d f e w e r years 
o f education, f e w e r stable j o b s a n d l o w e r m o n t h l y i n c o m e s than the H C g r o u p , b u t 
n o differences w e r e f o u n d b e t w e e n the Primarily K a n d P o l y K g r o u p s in these 
areas. M o r e participants in the Primarily K g r o u p expressed a religious preference 
relative to the H C g r o u p (p = 0.014). S e x a n d marital status w e r e distributed 
relatively e v e n l y across the three groups. A p p r o x i m a t e l y 8 3 % o f the participants 
w e r e recruited f r o m non-residential c o m m u n i t y service centres. T h e d e m o g r a p h i c 
characteristics o f the study population are s u m m a r i s e d in T a b l e 3. 
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Table 3 Descriptive statistics of demographic characteristics 
HC 
N = 100 
Primarily K 
N = 100 
Poly K 
N = 100 
20.6 ± 3.6 
Sex (female), n (%) 
Education (in years) 
42 (42.0) 
11.7 ± 2.4 
Marital status (single) 
Monthly income 
96 (96.0) 
$5,467 ± : 
Occupation 
Employed/homemaker/student 96 (96.0) 
Unemployed 








22.4 ± 4.2 
(p = 0.003)* 
47 (37.0) 
.± 1.8 
(p = 0.000)* 
95 (95.0) 
(p = 0.002)* 
47 (47.0) 





(P = 0.014)* 
20.4 ± 3.9 
(p = 0.001)** 
44 (44.0) 
9.2 ± 1.9 
(p = 0.000)* 
92 (92.0) 
$2,971 ± $4,713 $2,342 ± $4,244 
(p = 0.000)* 
52 (52.0) 






< 0.001 ‘ 
0.445 b 
0.036b 
*Compared with HC group; **compared with Primarily K group. Adjusted significance level is 
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3.2 Drug use patterns 
Participants' d r u g u s e patterns are g i v e n in T a b l e 4. T h o s e in the P o l y K 
g r o u p exhibited a significantly higher f r e q u e n c y o f u s e o f psychotropic d r u g s other 
than k e t a m i n e . T h e 3 m o s t c o m m o n l y u s e d d r u g s in the past 2 years a m o n g the 
P o l y K users w e r e k e t a m i n e , f o l l o w e d b y cocaine a n d m e t h a m p h e t a m i n e . T h e 
self-report s u r v e y results o n lifetime d r u g u s e in the P o l y K g r o u p s h o w e d 6 8 % to 
h a v e u s e d cocaine, 5 6 % cannabis, 5 0 % m e t h a m p h e t a m i n e , 4 8 % ecstasy a n d 4 6 % 
hypnotics. O n l y o n e participant reported opioid u s e in past t w o years. F e w e r 
participants in the Primarily K g r o u p reported the lifetime u s e o f other drugs, w i t h 
3 8 % reporting cocaine use, 2 8 % cannabis, 2 7 % m e t h a m p h e t a m i n e , 3 1 % ecstasy 
a n d 2 6 % hypnotics. T h e Primarily K g r o u p h a d earlier e x p o s u r e to d r u g u s e (p = 
0.006), h a d u s e d k e t a m i n e m o r e frequently in the past m o n t h (p = 0.003) a n d w a s 
less likely to abstain f r o m k e t a m i n e u s e (p = 0 . 0 1 5 ) than the P o l y K group. T h e H C 
g r o u p reported n o history o f d r u g use. T h e Primarily K g r o u p s h a d b o t h higher 
lifetime (p = 0.018) a n d current k e t a m i n e d e p e n d e n c e (p < 0.001). T h e Primarily K 
a n d P o l y K g r o u p s scored similarly o n the S D S a n d ASI-Lite. N o difference w a s 
f o u n d in the level o f alcohol u s e across the g r o u p s (Table 4). 
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Table 4 Descriptive statistics of drug use patterns in three groups 
Variable 
HC 
N = 100 
Primarily K 
N = 100 
Poly K 
N = 100 








Total days of drug use 
Total days of drug use in past month 
Alcohol use in past month (days) 
Ketamine use in past month (days) 
Duration of Ketamine use (months) 
Age of first use of drug 
General duration (months) 
Abstinent for more than 1 month 
SDS 
Lifetime dependence on ketamine 
Current dependence on ketamine 
2.3 ± 5.9 
364.3 ± 237.2 429.3 ± 209.9 0.031a 
1.9 ± 7.6 
0.9 ± 3.5 
.6 ± 5.4 
0.8 ± 3.7 
• ± 12.1 
4.2 ± 7.7 
• ± 11.7 
15.4 ± 2.9 
64.0 ± 35.2 
49 (49) 




441.7 ± 212.5 532.1 ± 
4.3 ± 9.1 
17.1 ± 3.5 
66 (66) 
7.2 ± 4.0 
79 (84.0%) 
< 0.001a 
： ± 1 3 0 . 1 < 0 . 0 0 1 a 
± 127.8 < 0.001a 
0.011a 
19.1 ± 55.4 < 0.001a 
.6 ± 36.5 0.317 a 
0.005b 
�b ± 15.5 0.287 
4.3 ± 7.0 0.272a 
0.003a 
； ± 3 4 . 6 3 5 6 . 0 9 ± 3 7 . 3 5 0 . 4 1 1 b 
0.006b 
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ASI Composite Score - Medical 0.18 ± 0.25 ； ± 0 . 3 4 0.28 ± 0.32 0.065a 
ASI Composite Score - Employment 0.35 ± 0.72 0.120 ± 0.97 0.25 ± 0.87 0.551a 
ASI Composite Score - Alcohol 
ASI Composite Score - Drugs 
ASI Composite Score - Legal 
ASI Composite Score - Family 
ASI Composite Score - Psychiatry 
0.11 ± 0.0 
± 0.15 
± 0.14 
0.12 ± 0.11 
0.10 ± 0.08 
0.06 ± 0.29 
0.45 ± 0.17 
0.23 ± 0.18 
0.12 ± 0.07 0.195a 
0.07 ± 0.07 < 0.001a 
0.05 ± 0.28 0.137a 
0.48 ± 0.17 0.080a 
0.28 ± 0.25 < 0.001a 
aMann-Whitney U-test; bt- test; cChi-square test 
All o f the participants in the t w o d r u g u s e g r o u p s h a d b e g u n u s i n g 
psychotropic d r u g s other than cocaine b y the a g e o f 18. T h e majority t o o k d r u g s 
w i t h their peers at h o m e or at their peers' h o m e s . T h e m o s t p o p u l a r administration 
route for k e t a m i n e w a s via nasal inhalation, w h e r e a s that for c o c a i n e w a s 
inhalation in a cigarette (see T a b l e 5). 
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Table 5 Patterns of drug use 
Ketamine Cocaine Ecstasy Methamphetamine Cannabis Hypnotics 
N = 200 N = 105 N = 78 N = 73 N = 73 N = 70 
Days of use in past 2 
years 
396.8 ± 225.7 1 1 2 . 8 士 
163.0 
25.1 ± 61.2 78.0 ± 142.9 32.8 ± 102.3 67.2 ± 145.9 
Days/month in past 2 16/month 4/month 4/month 4/month 1/month 2/month 
years (median) 
Age of first use of 16.0 ± 3.0 18.0 ± 3.3 15.8 ± 2.2 16.7 ± 3.0 15.2 ± 2.2 16.3 ± 2.9 
drug 
Duration (months) 58.2 ± 36.0 32.3 ±32.6 35.4 ± 32.5 27.0 ± 27.4 42.0± 40.4 36.6 ± 36.7 
Place Home or Home or Disco Home or peer's Home or Disco 
The most, n (%) peer's home peer's home home peer's home 34 (48.6) 
116 (58.0) 52 (49.5) 47 (60.3) 61 (83.6) 28 (38.4) 
With whom With peers With peers With peers With peers With peers With peers 
The most, n (%) 143 (71.5) 89 (84.8) 66 (84.6) 57 (78.1) 51 (69.9) 52 (74.3) 
Route of Nasal Cigarette to Oral Smoking Cigarette to Oral 
administration 198 (99.0) inhale 68 (93.2) 48 (65.8) inhale 62 (88.6) 
The most, n (%) 89 (84.8) 62 (84.9) 
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3.3 Comorbid psychiatric problems 
A s s h o w n in T a b l e 6, participants in the Primarily K a n d P o l y K g r o u p s 
h a d higher B D I a n d H A D S A scores than those in the H C g r o u p (p < 0 . 0 0 1 a n d p = 
0.005, respectively). Participants in these t w o g r o u p s w e r e also m o r e likely to 
present w i t h psychotic s y m p t o m s (p = 0.076) a n d to h a v e a history o f psychiatric 
outpatient treatment (p = 0.028). T h e n u m b e r o f participants in the t w o d r u g u s e 
g r o u p s w h o w e r e d e e m e d to require a psychiatric diagnostic interview b a s e d o n the 
study criteria varied f r o m 7 7 % to 8 7 % , b u t less t h a n 6 0 % o f those in b o t h g r o u p s 
actually attended the interview, a n d the cross-group attendance rate w a s similar. 
O f those for w h o m a further interview w a s d e e m e d necessary, those w h o attended 
the interview t e n d e d to scored h i g h e r o n the B D I a n d H A D S A than those w h o did 
n o t ( B D I : 17.1 士 10.3 v e r s u s 15.4 士 10.5; H A D S A : 7.5 士 4.0 versus 6.5 士 3.9), b u t 
the difference did n o t reach the significance level (p = 0 . 2 3 0 for the B D I , p = 0 . 0 7 4 
for H A D S A ) . 
O n e h u n d r e d a n d sixty-eight participants attended a psychiatric interview, 
a n d 7 7 o f t h e m received a diagnosis o f either a past ( N = 17) or current ( N = 6 2 ) 
psychiatric disorder. M o o d disorders constituted the m o s t c o m m o n psychiatric 
diagnosis. Sixteen o u t o f 1 7 past psychiatric disorders w e r e depressive disorders 
a n d 1 w a s general anxiety disorder. Similarly, 5 1 o f the 6 2 d i a g n o s e s o f current 
psychiatric disorders w e r e depressive disorders, 2 5 w e r e anxiety disorders, 6 w e r e 
psychotic disorders, a n d 4 w e r e m i x e d m o o d disorders. T h e r e w a s n o significant 
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cross-group difference in the t y p e o f diagnosis m a d e , a l t h o u g h there w a s a notable 
trend t o w a r d s m o r e psychiatric p r o b l e m s in k e t a m i n e users. 
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Table 6 Psychiatric problems in three groups 
Variable 
H C 
N = 1 0 0 
Primarily K 
N = 1 0 0 
P o l y K 
N = 1 0 0 
B D I score 
B D I > = 15, n ( % ) 
H A D S A score 
H A D S A > = 8, n ( % ) 
Psychotic s y m p t o m , n ( % ) 
P r e v i o u s visit in a psychiatric 
outpatient setting 
Psychiatric interview required, n 
( % ) 
Psychiatric interview attended, n 
( % ) 
P a s t diagnosis, n ( % ) 
C u r r e n t diagnosis, n ( % ) 
M o o d disorders, n ( % ) 
Substance-induced depressive 
disorder, n (%) 
9.14 ± 8 . 1 2 9 16.29 ± 10.56 17.12 ± 11.59 < 0 . 0 0 1
a 
4 9 (49.0) 
.73 ± 3.68 
2 9 (29.0) 
10 (10.0) 
0.01 ± 0.10 
7 7 (76.0) 




(p < 0.001)* 
7 8 (78.0) 
3 3 (33.0) 
13 (13.0) 
8 3 (83.0) 
5 6 (56.0) 
2 (2.0) 
2 5 (25.0) 
2 1 (21.0) 
1 7 (17.0) 
(p < 0.001)* 
7 8 (78.0) 
(p = 0 . 0 0 9 ) * * 
4 0 (40.0) 
2 3 (23.0) 
8 7 (85.0) 
11 (11.0) 
2 3 (23.0) 
2 1 (21.0) 
< 0 . 0 0 1 
b 
.57 ± 3.76 7.30 ± 4 . 7 9 0 . 0 0 5
a 
(p = 0.020)* 
0 . 2 5 1 
b 
0 . 0 7 6 
b 
0.16 ± 0.53 0.48 ± 2.12 0 . 0 2 8
c 
(p = 0.024)* 
0 . 1 7 5 
b 
5 8 (58.0) 0 . 4 4 5
b 
0 . 0 5 7 
b 
0 . 2 5 6 
b 
0 . 2 4 2 
b 
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Substance-induced mixed 
disorder, n (%) 
2 (2.0) 0 (0.0) 0 . 4 6 0
e 
Substance-induced dysthymic 
disorder, n (%) 
- 1 (1.0) 0 (0.0) 0 . 9 8 6
e 
Non-substance-induced 
depressive disorder, n (%) 
11 (11.0) 1 (1.0) 2 (2.0) -
A n x i e t y disorders, n ( % ) 9 (9.0) 5 (5.0) 11 (11.0) 0 . 4 9 6
b 
Substance-induced anxiety 
disorder, n (%) 
- 1 (1.0) 3 (3.0) 0 . 4 9 6
e 
Psychotic disorders, n ( % ) 0 (0.0) 2 (2.0) 4 (4.0) 0 . 2 9 9
b 
Substance-induced psychotic 
disorder, n (%) 
- 1 (1.0) 3 (3.0) 0 . 7 8 9
e 
Non-substance-induced 
psychotic disorder, n (%) 
0 (0.0) 1 (1.0) 1 (1.0) -
aANOVA; bchi-square test; cMann-Whitney U-test; dt-test; eFisher's exact test. 
^Compared with HC group; **compared with Primarily K group. Adjusted significance level is 
0.017 for post hoc comparisons. 
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3.4 Cognitive functions 
3.4.1 Cognitive functions among primarily ketamine, poly-ketamine and control 
groups 
Univariate analysis identified cross-group differences in general 
intelligence (Digit S y m b o l - C o d i n g , Arithmetic a n d Information), verbal m e m o r y 
( W M S - I I I L o g i c a l M e m o r y a n d w o r d list, visual m e m o r y ( R O C F ) , executive 
function ( W C S T , Stroop test a n d V F ) , l a n g u a g e a n d m o t o r s p e e d ( D S C a n d Stroop 
total reaction time) (Table 7). After a d j u s t m e n t for age, sex, education a n d B D I 
score, significant differences r e m a i n e d across g r o u p s in W M S - I I I L o g i c a l M e m o r y 
i m m e d i a t e a n d d e l a y e d recall a n d in R O C F i m m e d i a t e , d e l a y e d recall, savings a n d 
recognition (Table 7). In post h o c c o m p a r i s o n s , the Primarily K g r o u p p e r f o r m e d 
w o r s e than the H C g r o u p o n W M S - I I I L o g i c a l M e m o r y i m m e d i a t e (p = 0 . 0 0 8 ) a n d 
d e l a y e d recall (p = 0.003), R O C F d e l a y e d recall (p = 0 . 0 1 0 ) a n d R O C F savings (p 
= 0 . 0 1 5 ) . T h e differences b e t w e e n the t w o g r o u p s w e r e borderline in the w o r d list 
i m m e d i a t e recall (p = 0.055), d e l a y e d recall (p = 0 . 0 2 2 ) a n d recognition (p = 
0.070). T h e P o l y K g r o u p p e r f o r m e d w o r s e than the H C g r o u p o n L o g i c a l M e m o r y 
d e l a y e d recall (p = 0.010), R O C F i m m e d i a t e recall (p = 0.013), R O C F d e l a y e d 
recall (p = 0.002), R O C F savings (p = 0.002) a n d R O C F recognition (p = 0.011). 
After a d j u s t m e n t b y age, sex a n d H A D S A score, the Primarily K g r o u p h a d a 
l o w e r R O C F recognition score than the P o l y K g r o u p (p = 0.015). 
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Table 7 Performance on cognitive tests among three groups 
HC Primarily K Poly K Pa 
N = 100 N = 100 N = 100 
R square 
WAIS-III DSC 92.8 ± 15.7 79.3 ± 17.0 82.7 ± 16.5c <0.001 0.079 0.249 
WAIS-III Arithmetic 15.9 ± 3.4c 13.0 ± 4.1 13.2 ± 4.1c <0.001 0.164 0.223 
WAIS-III Information 14.8 ± 4.6 11.0 ± 4.2 10.6 ± 4.2 c <0.001 0.043 0.353 
WAIS-III DSF 15.2 ± 1.5 15.5 ± 1.0 15.1 ± 1.3 .169 0.033 0.021 
WAIS-III DSB 9.3 ± 3.1 8.3 ± 3.3 8.8 ± 3.2 0.090 0.092 0.096 
WMS-III Logical Memory: immediate recall 38.2 ± 10.2 26.2 ± 13.9cd 29.9 ± 11.7 <0.001 0.002 0.262 
WMS-III Logical Memory: delayed recall 
WMS-III Logical Memory: recognition 
WMS-III Logical Memory: retention 
WMS-III word list: first total recall 
WMS-III word list: delay recall 
WMS-III word list: recognition 
WMS-III word list: retention 
ROCF: copy 
ROCF: immediate recall 
ROCF: delayed recall 
ROCF: savings 
ROCF: recognition 
WCST: total trials 
22.9 ± 7.1 14.7 ± 8.8c 17.0 ± 7.8c <0.001 <0.001 0.233 
24.6 ± 2.9 22.3 ± 3.8 23.2 ± 3.4 <0.001 0.118 
85.5 ± 17.0 80.4 ± 26.5 79.8 ± 18. 
33.4 ± 5.4 30.0 ± 5.8 31.1 ± 6.c <0.001 0.078 
8.4 ± 2.1 
82.8 ± 15.7 8 0 . 2 士 
.181 
S o . 8 8 1 价 1 1
.104 
7.4 ± 2.4 7.6 ± 2.4 0.007 0.147 0.071 
23.3 ± 1.0 22.8 ± 1.7 23.1 ± 1.4 0.043 0.213 0.060 
0.360 0.597 0.004 
33.6 ± 2.2 32.7 ± 3.2 32.9 ± 2.9 0.071 0.333 0.040 
23.6 ± 6.8 19.2 ± 7.4 18.5 ± 7.5c <0.001 0.041 0.123 
24.1 ± 6.1 19.3 ± 7.3c 18.6 ± 7.7c <0.001 0.006 0.144 
71.7 ± 17.3 58.4 ± 20.6c 56.4 ± 22.4c <0.001 0.008 0.139 
20.6 ± 1.9 20.0 ± 2.4 19.3 ± 2.4 <0.001 0.023 0.066 
89.2 ± 19.5 96.8 ± 20.6 98.9 ± 20.6 0.002 0.711 0.099 
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WCST: category completed 1 士 0.9 5.4 士 .4 士 .133 0.657 0.078 
WCST: preservative 9.6 ± 8. 13.2 ± 11.1c 12.8 ± 12.2 0.031 0.089 
Stroop test: interference (seconds) 20.7 ± 7.1 24.4 ± 7.0 c 23.5 ± i 0.000 0.306 0.083 
Stroop test: total reaction time (seconds) 51.5 ± 14.1 56.3 ± 15.3 55.3 ± 13.5 0.043 0.649 0.050 
Stroop test: total ‘士 1.8 2.7 ± 2.3 2.6 ± 2.3c 0.003 0.907 0.093 
VF: total correct responses 4 5 . 0 ± 9.1 4 0 . 9 ± ： <0.001 0.367 0.186 
Language 14.8 ± 0.5 14.6 ± 0.7 14.7 ± 0.5 0.010 0.163 0.030 
aANOVA; bunivariate GLM, adjusted for age, sex, years of education and BDI total score; cpost hoc 
comparisons, significantly different from HC, significance level = 0.017; dpost hoc, significantly 
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In the Primarily K g r o u p , the d a y s o f k e t a m i n e u s e in the m o s t recent 
m o n t h a n d the duration o f abstinence w e r e significantly correlated w i t h 4 a n d 3 
m e m o r y variables, respectively. T h e duration o f k e t a m i n e u s e in this g r o u p w a s 
related o n l y to L o g i c a l M e m o r y i m m e d i a t e recall, whilst the n u m b e r o f d a y s o f 
k e t a m i n e u s e in the past 2 years w a s n o t correlated w i t h a n y o f the m e m o r y 
variables (Table 8). Standardisation w a s p e r f o r m e d o n the L o g i c a l M e m o r y 
i m m e d i a t e a n d d e l a y e d recall a n d R O C F i m m e d i a t e a n d d e l a y e d recall scores, a n d 
a total m e m o r y score w a s generated b y s u m m i n g u p the 4 standardised scores. 
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Table 8 Correlation of drug use patterns and memory in Primarily K group 
Ketamine use Ketamine use in Duration of 
Duration of in past 2 recent month abstinence 












5 8 1 1 
0.065 
WMS-III Logical r 
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3.4.2 Cognitive functions in current primarily ketamine and ex-primarily 
ketamine users 
T o clarify the reversibility o f k e t a m i n e ' s effects, c o m p a r i s o n w a s m a d e 
b e t w e e n the current a n d e x - d r u g users in the Primarily K group. T h e definition o f 
a n ex-user in the Primarily K g r o u p w a s abstinence f r o m k e t a m i n e for at least o n e 
m o n t h [ M o r g a n et al. 2 0 0 9 ] Forty-nine m e m b e r s o f this g r o u p w e r e classified as 
e x - k e t a m i n e users ( E K ) a n d 5 1 as current k e t a m i n e users ( C K ) . A N O V A revealed 
b o t h the C K a n d E K g r o u p s to b e older a n d less e d u c a t e d t h a n the H C g r o u p (p = 
0 . 0 0 3 a n d p < 0.001, respectively). T h e k e t a m i n e u s e patterns w e r e similar 
b e t w e e n the C K a n d E K g r o u p s in t e r m s o f a g e at first exposure, total f r e q u e n c y o f 
u s e in the past t w o years, duration o f k e t a m i n e use, S D S scores a n d the level o f 
other d r u g u s e (Tables 9 a n d 10). H o w e v e r , the C K g r o u p s h a d significantly higher 
B D I scores than either the E K (20.6 士 10.1 v e r s u s 11.8 士 9.1, p < 0 . 0 0 1 ) or H C 
g r o u p (20.6 士 10.1 versus 9.1 士 8.1, p < 0 . 0 0 1 ) (Table 9). 
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Table 9 Demographics and reported estimates of ketamine use in the two Primarily K and HC 
CK EK HC P-valuea 
N = 51 N = 49 N = 100 
Male, n (%) 29 (56.9) 24 (49.0) 58 (58.0) 
22.8 ± 4.3c 22.0 ± 4.0 20.6 ± 3.6 0.003 
Education, years 9.7 ± 1.9c ± 1.7c 11.7 ± 2.4 < 0.001 
Age first used ketamine, (range) years 17.2 ± 3.2 16.6 ± 3.0 0.280d 
(11-25) (12-26) 
Total years of ketamine .3 ± 2.8 4.7 ± 3. 0.336d 
Frequency of ketamine use in past 2 19.8 ± 1 19.8 ± 11. 0.997d 
years, days per month 
Current frequency of ketamine use, days 17.4 ± 1 
per month 
Days since last use of ketamine (range) 3.4 ± 8.3 196.6 ± 163. < 0.001 d 
days (0-30) (31-639) 
SDS 8.2 ± 3. 
20.6 ± 10. i c , f 
7.4 ± 3.8 
11.8 ± 9.1 
0.249 
< 0.001 
！ > / = 1 5 37 (72.5)' ,c,f 15 (30.6) 20 (20.0) < 0.001 b 
aANOVA unless otherwise specified; bchi-square test; cpost hoc comparison, significantly different 
from HCs; dt-test; efrequency of use just before stopping in EKs, months since stopping in EKs; 
fpost hoc comparison, significantly different from EKs. 
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Table 10 Reported estimates of use of drugs other than ketamine by current and ex-Primarily 
K users 
CK 
N = 51 
EK 
N = 49 
P-value 
Cocaine 
Age first used, years 
Total years of use 
Frequency of use in past two years, days per month ‘ 
Current frequency of use of, days per month 
Days since last use, days 
Ecstasy 
Age first used, years 
Total years of use 
Frequency of use in past two years, days per month ‘ 
Current frequency of use of, days per month 
Days since last use, days 
Methamphetamine 
Age first used, years 
Total years of use 
Frequency of use in past two years, days per month ‘ 
Current frequency of use of, days per month 
Days since last use, days 
Sedatives and hypnotics 
19.1 ± 3 . 7 
0.9 士 1.9 
2 . 0 士 2 . 7 
0.5 ± 1.1 
1 3 8 ± 3 4 7 
17.1 ± 2 . 9 
1.0 士 2 . 0 
8.9 ± 1 0 . 2 
0.2 士 1.0 
9 1 3 ± 1 1 2 9 
0.2 士 1.0 
3 . 0 士 3 . 4 
0 . 0 7 士 4 . 2 
1 3 3 ± 2 8 0 
18.5 ± 3.3 
0.9 士 2.1 
6 . 7 士 10.4 
0.1 士 0.6 
3 7 1 ± 5 8 2 
1 5 . 4 ± 2.1 
1.0 士 2.3 
8.4 ± 1 0 . 7 
0.9 士 2.3 
8 0 6 ± 1 0 7 1 
1 6 . 0 士 2.5 
0.9 士 2.3 
5.9 士 8.7 
0 . 0 2 士 0.8 
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Age first used, yea 
Total years of use 
Current frequency of use of, days per month 
Days since last use, days 
Cannabis 
Age first used, years 
Total years of use 
Frequency of use in past two years, days per month 
Current frequency of use of, days per month 
Days since last use, days 
Alcohol 
Age first used, yea 
Total years of use 
1 6 . 7 士 3 . 4 
0 . 7 士 1.7 
Frequency of use in past two years, days per month c 5.4 ± 9.3 
0.02 ± 0.14 
3 3 4 士 5 0 3 
1 5 . 6 士 2.3 
0 . 7 士 2 . 0 
1.2 ± 1.1 
0.0 士 0.0 
4 7 0 ± 7 3 5 
1 4 . 2 士 4.8 
士 6.0 
1 6 . 2 士 2.6 
1.0 士 3 . 0 
8.3 ± 11.2 
0.0 士 0.0 
8 6 6 ± 1 0 9 6 
1 4 . 4 ± 1.5 
1.5 ± 3 . 7 
1.8 士 2.3 
0.0 士 0.0 
8 8 2 ± 1 0 2 6 













aT-test; bMann-Whitney U-test;c frequency of use just before stopping in EKs. 
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After a d j u s t m e n t for age, sex a n d years o f education, differences w e r e 
f o u n d across the three g r o u p s in m o s t o f the m e m o r y i n d e x e s (Table 11). P o s t h o c 
analyses w e r e subsequently c o n d u c t e d t h r o u g h multiple c o m p a r i s o n s : b e t w e e n the 
C K s a n d H C s , E K s a n d H C s , a n d C K s a n d E K s . B o n f e r r o n i a d j u s t m e n t w a s 
adopted, w i t h the significant p v a l u e set at 0.017. Multiple c o m p a r i s o n s w e r e also 
carried o u t u s i n g a univariate G L M to adjust for c o n f o u n d i n g factors. T h e C K 
g r o u p displayed significantly p o o r e r p e r f o r m a n c e than the H C g r o u p s in the 
W A I S - I I I Digit S y m b o l - C o d i n g (p = 0.006), W M S - I I I L o g i c a l M e m o r y 
i m m e d i a t e (p = 0 . 0 0 2 ) a n d d e l a y e d recall (p = 0 . 0 0 2 ) a n d R O C F c o p y (p = 0.015), 
i m m e d i a t e recall (p = 0.006), d e l a y e d recall (p = 0.002) a n d savings (p = 0.006). 
T h e r e w a s also a trend for the C K s to p e r f o r m w o r s e t h a n the H C s o n Arithmetic 
(p = 0.082) a n d the M V F T (p = 0.083). 
T h e C K g r o u p also d e m o n s t r a t e d significantly p o o r e r p e r f o r m a n c e t h a n the 
E K g r o u p o n the W M S - I I I L o g i c a l M e m o r y i m m e d i a t e a n d d e l a y e d recall (ps = 
0 . 0 0 1 ) a n d retention (p = 0.018), W M S - I I I w o r d list i m m e d i a t e recall (p = 0.007), 
R O C F c o p y (p = 0.005), i m m e d i a t e recall (p = 0.000), d e l a y e d recall (p = 0.002), 
a n d savings (p = 0.009), Stroop test total reaction t i m e (p = 0 . 0 0 1 ) a n d the M V F T 
(p = 0.004). T h e E K s h a d a slightly higher D S F score t h a n the H C s (p = 0.006), 
b u t there w a s otherwise n o difference b e t w e e n t h e m . 
Correlational analysis indicated the B D I score to b e negatively correlated 
w i t h the Arithmetic, D S B , L o g i c a l M e m o r y ( i m m e d i a t e recall), a n d w o r d list 
i m m e d i a t e recall, d e l a y e d recall a n d recognition scores. T h e B D I score w a s also 
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negatively related to the other L o g i c a l M e m o r y (delayed recall a n d recognition) 
a n d R O C F scores ( i m m e d i a t e recall a n d savings), b u t at a borderline d e g r e e o f 
significance (Table 12). 
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Table 11 Group scores on cognitive assessments in comparison of current and ex-Primarily 
ketamine users and healthy controls 
CK 
N = 51 
EK 
N = 49 
HC 






WAIS III DSB 
WMS-III Logical Memory: delayed recall 
WMS-III Logical Memory: recognition 
WMS-III Logical Memory: retention 
WMS-III word list: immediate recall 
WMS-III word list: delay recall 
WMS-III word list: recognition 
WMS-III word list: retention 
ROCF: copy 
ROCF: immediate recall 
ROCF: delayed recall 
ROCF: savings 
ROCF: recognition 
WCST: total trials 
73.9 ± 14.6b 
12.5 ± 4.1 
10.5 士 3 . 9 
15.3 士 1.1 
7.4 士 3. 
WMS-III Logical Memory: immediate recall 21.0 ± 10.7b , ’c 
1 1 . 2 士 6.9^ "’。 
2 1 . 1 ± 3 . 9 
7 4 . 7 士 2 6 . 3 c 
4 . 6 士 1.5 c 
6.8 士 2 . 6 
2 2 . 5 ± 2.1 
8 0 . 0 ± 2 0 . 9 
3 2 . 0 士 3.5b’c 
1 6 . 4 士 7.7b’c 
1 7 . 0 士 7.7b’c 
5 2 . 5 ± 2 2 
2 0 . 0 士 2 . 7 
1 0 2 . 2 ± 2 0 . 
bc 
85.1 ± 17.9 92.9 ± 15.8 0.003 
13.4 ± 4.0 
11.5 ± 4.4 
1 5 . 6 士 0.9 b 
9.3 士 3.3 
3 1 . 5 ± 12.9 
2 3 . 5 士 3.4 
8 6 . 3 ± 2 5 . 8 
5.9 ± 1.7 
8.0 士 2 . 2 
2 3 . 1 ± 1.0 
7 7 . 6 ± 2 5 . 2 
3 3 . 5 士 2 . 7 
2 2 . 1 ± 5.9 
2 1 . 8 ± 6.2 
6 4 . 6 ± 16.6 
2 0 . 1 ± 1.0 
9 1 . 1 ± 19.6 
1 5 . 9 士 3.4 
14.8 士 4.6 
1 5 . 2 士 1.5 
9.3 士 3. 
.8 ± 
8.4 士 2. 
23.3 ± 1.0 
82.8 ± 15. 






38.2 ± 10.2 < 0.001 
22.9 ± 7.1 < 0.001 
24.6 ± 2.9 0.032 







24.1 ± 6.1 < 0.001 
71.7 ± 17.3 0.002 
20.6 ± 1.9 0.912 
89.2 ± 19.5 0.046 
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WCST: category completed 士 .6 士 1.2 ‘士 0.9 . 1 4 9 
WCST: preservative 丨 15.2 ± 12. 11. 9 . 6 士 8. 0 . 0 9 7 
Stroop test: interference (seconds) 2 5 . 3 士 8.2 2 3 . 5 士 5.5 2 0 . 7 ± 7.1 0 . 2 6 9 
Stroop test: total reaction time (seconds) 6 1 . 9 ± 1 7 . 2 c 5 0 . 5 + 10.5 5 1 . 5 + 14.1 0 . 0 0 3 
Stroop test: total 2.5 ± 2. 2 . 7 ± 2.3 ± 1.8 0.608 
MVFT 3 7 . 9 士 7 . 5 c 4 4 . 0 士 9.2 4 5 . 0 ± 9.1 0.006 
Language 1 4 . 7 士 0 . 7 14.5 士 0.7 14.8 士 0.5 . 1 3 5 
aUnivariate GLM, adjusted for age, sex, years of education and BDI score; post hoc comparison, 
significantly different from HCs; cpost hoc comparison, significantly different from EKs. 
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Table 12 Correlations between BDI and cognitive assessment scores in current Primarily 
ketamine users (N = 51). 
Pearson's correlations P-value 
WAIS-III Digit Symbol-Coding -0.193 
WAIS-III Arithmetic -0.347 
WAIS-III Information -0.250 
WAIS-III DSF 0.063 
WAIS-III DSB -0.335 
WMS-III Logical Memory: immediate 
recall -0.284 
WMS-III Logical Memory: delayed recall -0.251 
WMS-III Logical Memory: recognition -0.256 
WMS-III Logical Memory: retention 0.069 
WMS-III word list: immediate recall -0.298 
WMS-III word list: delay recall -0.484 
WMS-III word list: recognition -0.309 
WMS-III word list: retention -0.271 
ROCF: copy 0.111 
ROCF: immediate recall -0.272 
ROCF: delayed recall -0.212 
ROCF: savings -0.241 
ROCF: recognition -0.196 
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WCST: category completed -0.078 0.588 
WCST: preservative errors 0.011 0.939 
Stroop test: time (seconds) 0.126 0.384 
Stroop test: total errors 0.147 0.307 
MVFT -0.174 0.221 
Language -0.071 0.154 
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3.4.3 Cognitive functions in current and ex-poly-ketamine users 
T a b l e 13 presents the c o m p a r i s o n s b e t w e e n the t w o s u b g r o u p s o f P o l y K 
users a n d H C s . T h e P o l y K users w e r e categorised into e x - ( E P K s ) a n d current 
users ( C P K s ) , b o t h o f w h i c h h a d a l o w e r education level a n d h i g h e r B D I total 
score than the H C group. M o r e o v e r , the B D I total score w a s higher in the C P K 
g r o u p than in the E P K g r o u p (p < 0.001), although there w a s n o difference 
b e t w e e n t h e m in the S D S score or total f r e q u e n c y o f a n y d r u g u s e other than 
m e t h a m p h e t a m i n e (p = 0.039). 
In t e r m s o f cognitive function, after a d j u s t m e n t s for age, sex, years o f 
education a n d B D I score, general cross-group differences w e r e f o u n d o n the visual 
m e m o r y a n d verbal m e m o r y i n d e x e s (Table 14). P o s t h o c analyses w e r e 
subsequently c o n d u c t e d b e t w e e n the C P K a n d H C , E P K a n d H C , a n d C P K a n d 
E P K g r o u p s via multiple c o m p a r i s o n s w i t h B o n f e r r o n i adjustment. P v a l u e 
significance w a s set at 0.017. M u l t i p l e c o m p a r i s o n s w e r e also carried o u t u s i n g a 
univariate G L M to adjust for c o n f o u n d i n g factors. 
T h e C P K s h a d l o w e r scores than the H C s o n L o g i c a l M e m o r y d e l a y e d 
recall (p = 0.007), a n d they also t e n d e d to scored l o w e r o n R O C F d e l a y e d recall (p 
= 0 . 0 4 0 ) , R O C F savings (p = 0.045), R O C F recognition (p < 0.001) a n d the M V F T 
(p = 0.065). T h e E P K s h a d l o w e r scores than the H C s o n R O C F i m m e d i a t e recall 
(p = 0.016), R O C F d e l a y e d recall (p = 0 . 0 0 3 ) a n d R O C F savings (p = 0.004). T h e 
C P K a n d E P K g r o u p s a c h i e v e d similar scores o n the m e m o r y variables. 
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Table 13 Group scores on demographics and drug use patterns in comparison of current and 
ex-poly-drug ketamine users and healthy controls 
EPK CPK HC P-value 
N = 56 N =44 N = 100 
.8 ± 3.7 ± 4.1 20.6 + 3. 0.626a 
Male, N (%) 
Education (in years) 
32 (57.1) 
9.3 ± 1.8 
24 (54.5) 58 (58.0) 0.928b 
9.2 ± 2. 1 1 . 7 + 2 . 4 < 丨 
13.2 ± 10. 22.1 ± 11. + 8.13 < 0.001a 
SDS 7.2 ± 4.3 7.2 ± 3. 0.957a 
Total frequency (days in past 2 years) 
Any drug 536.3 ± 242.2 526.8 ± : 
Cocaine 118.0 ± 172.0 101.6 ± 166.0 
Methamphetamine 43.1 ± 133.9 77.3 ± 124.0 
Cannabis 23.5 ± 107.3 29.3 ± 76.. 
Ecstasy 18.5 ± 43. 19.8 ± 
Hypnotics 45.0 ± 91.2 51.3 ± 164.3 
Ketamine 374.7 ± 234.3 351.2 ± 242.7 









aANOVA; bchi-square test; cMann-Whitney U-test. 
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Table 14 Group scores on cognitive assessments in comparison of current and ex-poly-ketamine 
users and healthy controls 
EPKa CPKa HCa P-valuea 
N = 56 N =44 N = 100 
WAIS-III Digit Symbol-Coding 8 4 . 0 士 81.1 ± 16.3 15.7 0.949 
WAIS-III Arithmetic 13.7 ± 4.2 12.7 ± 4.1 15.9 ± 3.4 0.386 
WAIS-III Information 10.7 ± 4.5 10.5 ± 4.0 14.8 ± 4.6 .106 
WAIS-III DSF 15.2 ± 1.5 15.1 ± 1.4 15.2 ± 1.5 0.330 
WAIS-III DSB 9.3 ± 3. 9.2 ±3.2 9.3 ± 3. 0.323 
WMS-III Logical Memory: immediate recall 29.5 士 13.1 30.3 士 9.7 38.2 士 10.2 0.136 
WMS-III Logical Memory: delayed recall 17.1 ± 8.7 16.8 ± 6.5 22.9 ± 7.1 0.021 
WMS-III Logical Memory: recognition 23.4 ± 3.5 23.0 ± 3.3 24.6 ± 2.9 0.686 
WMS-III Logical Memory: retention 79.3 ± 17.9 80.5 ± 85.5 ± 17.0 0.198 
WMS-III Word list: immediate recall .2 ± 1 .3 ± 1 0.430 
WMS-III Word list: delayed recall 7.8 士 2 . 4 7.3 士 8.4 ± 2. .136 
WMS-III Word list: recognition 23.1 ± 1.4 23.0 ± 1.4 23.3 ± 1.0 0.285 
WMS-III Word list: retention 82.7 ± 17.7 77.0 ± 20.2 82.8 ± 15. 0.228 
ROCF: copy 32.9 ± 2.7 32.8 ± 3.1 33.6 ± 2.2 0.664 
ROCF: immediate recall 18.3 ± 7.7 18.8 ± 7.3 23.6 ± i 0.037 
ROCF: delayed recall 18.6 ±7.7 18.5 ±7.8 24.1 ± 6.1 0.009 
ROCF: savings 56.5 ± 22.6 56.2 ± 22.3 71.7 ± 17.3 0.010 
ROCF: recognition 19.7 ± 2.3 18.6 ± 2.5 20.6 ± 1.9 0.003 
WCST: number of trials administered 98.1 ± 21.0 100.0 ± 20.4 89.2 ± 19.5 0.842 
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WCST: per cent 11.3 ± 1 5 . 6 ± 1 0 . 3 4 2 
WCST: number of categories completed .5 士 0.9 .2 士 .7 ± 0.9 0 . 3 5 5 
Stroop test: interference (seconds) 2 2 . 7 ± 6.3 2 4 . 5 ± 7.4 2 0 . 7 ± 7.1 0 . 4 4 0 
Stroop test: total reaction time (seconds) 5 3 . 9 ± 13.0 5 7 . 2 ± 14.0 5 1 . 5 ± 1 4 . . 8 7 5 
Stroop test: total 2.3 ± 2. 3 . 0 ± 2. .7 ± 1.8 0 . 2 0 3 
MVFT 4 1 . 2 ± 3 6 . 9 ± 8.5 4 5 . 0 ± 9.1 0 . 0 5 5 
Language 1 4 . 6 ± 0.5 1 4 . 7 ± 0.5 14.8 ± 0.5 0 . 0 7 8 
aANCOVA, adjusted for years of education and BDI 丨 
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3.4.4 Cognitive functions in current primarily ketamine and current poly-drug 
ketamine users 
C o m p a r i s o n s w e r e also m a d e b e t w e e n the current users in b o t h d r u g u s e 
g r o u p s a n d the H C s . T h e C K s w e r e older than b o t h the C P K s (p = 0.001) a n d the 
H C s (p = 0.001), a n d b o t h d r u g g r o u p s h a d higher B D I scores a n d a l o w e r 
educational level than H C g r o u p (all p s < 0.001). T h e r e w e r e n o differences 
b e t w e e n the C K a n d C P K g r o u p s in t e r m s o f sex, years o f education or B D I scores, 
although they differed in the n u m b e r o f total d a y s o f k e t a m i n e u s e in the past 
m o n t h a n d past t w o years, w i t h the C K g r o u p h a v i n g m o r e d a y s o f s u c h u s e in 
b o t h periods (p < 0 . 0 0 1 a n d p = 0.017, respectively). T h e r e w a s n o difference in 
their f r e q u e n c y o f u s e o f other drugs. T h e C K g r o u p h a d a shorter m e a n interval 
b e t w e e n the last u s e o f k e t a m i n e a n d the a s s e s s m e n t date relative to the C P K g r o u p 
(p < 0.001), a n d also h a d a higher S D S score (p = 0 . 0 4 5 ) a n d higher p e r c e n t a g e o f 
lifetime (p = 0 . 0 2 0 ) a n d current k e t a m i n e d e p e n d e n c e (p = 0 . 0 0 3 ) (Table 15). 
After adjusting for age, sex, years o f education a n d B D I scores, 
cross-group differences w e r e also f o u n d in D S C , all four i n d e x e s o f the L o g i c a l 
M e m o r y test a n d the R O C F test, w o r d list recognition a n d the M V F T . P o s t h o c 
c o m p a r i s o n w a s p e r f o r m e d b e t w e e n the C K a n d C P K g r o u p s via a n age-adjusted 
univariate G L M . T h e C K g r o u p h a d l o w e r scores in L o g i c a l M e m o r y i m m e d i a t e (p 
= 0 . 0 0 1 ) a n d d e l a y e d recall (p = 0 . 0 0 2 ) a n d displayed a trend o f p o o r e r 
p e r f o r m a n c e o n L o g i c a l M e m o r y i m m e d i a t e recognition (p = 0.064), although the 
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C P K g r o u p p e r f o r m e d w o r s e o n R O C F recognition at a borderline level o f 
significance (p = 0.032) (Table 16). 
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Table 15 Comparison of demographics and drug use patterns among current primarily ketamine 
users, current poly-drug ketamine users and healthy controls 
CK CPK HC P-value 
N = 51 N =44 N = 100 
22.8 ± 4.3 ± 4.1 20.6 + 3. 0.001a 
Male, N (%) 
Education (in years) 
29 (56.9) 
9.7 ± 
24 (54.5) 58 (58.0) 
9.2 ± 2. 
0.928c 
11.7 + 2.4 < 0.001a 
20.6 ± 10. 22.1 ± 11. + 8.13 < 0.001a 
SDS 8.2 ± 3. 7.2 ± 3. 0.045b 
Lifetime dependence on ketamine 
Current dependence on ketamine 
58 (95.1%) 33 (80.5%) 
43 (70.5%) 17 (41.5%) 
0.020c 
0.003c 
Days since last use of ketamine (range) days 3.4 ± 8.3 54.6 ± 111. < r>d 
Ketamine use in past month (days) 17.4 ± 1 9.7 ± 11.8 < 0.001d 
Total drug use in past month (days) 19.1 ± 1 17.2 ± 19.. .152d 
Total drug use in past 2 year (days) 
Ketamine 464.4 ± 216.4 351.2 ± 242.7 0.017� 
Any drug 477.3 ± 216.8 526.8 ± 236. .110d 
Cocaine 7.6 ± 15.0 101.6 ± 166.0 < 0.001d 
Methamphetamine 2.0 ± 6. 77.3 ± 124.0 < 0.001d 
Cannabis 1.4 ± 5. 29.3 ± 76. 0.005 d 
Ecstasy ± 4.9 0.008 d 
Hypnotics 16 ± 4.8 51.3 ± 164.3 .131 ‘ 
Opioid 0.0 ± 0.0 0.0 ± 0.0 .000 d 
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aANOVA; bt-test; cchi-square test; dMann-Whitney U-test. 
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Table 16 Comparison of cognitive functions among current primarily ketamine users, current 
poly-drug ketamine users and healthy controls 
CK CPK HC P-valuea 
N = 51 N =44 N = 100 
WAIS-III DSC 73.9 ± 14.6 81.1 ± 16.3 15.7 0.008 
WAIS-III Arithmetic 12.5 ± 4.1 12.7 ± 4.1 15.9 ± 3.4 0.072 
WAIS-III Information 10.5 + 3.9 10.5 ± 4.0 .126 
WAIS-III DSF 15.3 ± 1.1 15.1 ± 1.4 15.2 ± 1.5 0.334 
WAIS-III DSB 7.4 ± 3. 9.2 ±3.2 9.3 ± 3. 0.054 
WMS-III Logical Memory: immediate recall 21.0 ± 10.7 30.3 ± 9.7 38.2 ± 10.2 0.000 
WMS-III Logical Memory: delayed recall 11.2 ± .5 22.9 ± 7.1 0.000 
WMS-III Logical Memory: recognition 21.1 ± 3.9 23.0 ± 3.3 24.6 ± 2.9 0.005 
WMS-III Logical Memory: retention 74.7 ± 80.5 ± 1 85.5 ± 17.0 0.017 
WMS-III Word list: immediate recall 4.6 ± 53 ± .106 
WMS III Word list: delayed recall .8 ± 2. 7.3 ± 2. 8.4 ± 2. 0.083 
WMS-III Word list: recognition 22.5 ± 2.1 23.0 ± 1.4 23.3 ± 1.0 0.046 
WMS-III Word list: retention 80.0 ± 24.8 77.0 ± 20.2 82.8 ± 15. 0.318 
ROCF: copy 32.0 ± 3.5 32.8 ± 3.1 33.6 ± 2.2 0.038 
ROCF: immediate recall 16.4 ± 7.7 18.8 ± 7.3 23. 0.012 




52.5 ± 22. 
20.0 ± 2.7 
56.2 ± 22.3 71.7 ± 17.3 0.022 
18.6 ± 2.5 20.6 ± 1.9 0.024 
102.2 + 20.1 100.0 ± 20.4 89.2 ± 19.5 0.481 
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WCST-PE 15.2 + 12.6 15.6 ± 14.8 0.799 
WCST-category + 1 .2 ± .7 ± 0.9 .801 
Stroop test: interference (seconds) 25.3 ± 8.2 24.5 ± 7.4 20.7 ± 7.1 0.327 
Stroop test: total reaction time (seconds) 61.9 ± 17.2 57.2 ± 51.5 ±14. 0.060 
Stroop test: 2.5 ± 2. 3.0 ± 2. .7 ± 1.8 0.721 
MVFT 37.9 ± 7.5 .5 45.0 ± 9.1 0.047 
Language 14.7 ± 0.7 14.7 ± 0.5 14.8 ± 0.5 0.072 
aUnivariate GLM, adjusted for age, sex, years of education and BDI 
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3.4.5 Cognitive functions in female and male primarily ketamine users 
S e x differences in the d e m o g r a p h i c s a n d cognitive functions o f the Primarily 
K users w e r e e x a m i n e d u s i n g 2 ( s e x ) * 2 ( g r o u p ) A N O V A . G r o u p w a s f o u n d to h a v e 
a significant m a i n effect o n a g e (p = 0.002), w i t h users older t h a n the H C s overall. 
In generally, the H C s h a d spent m o r e years in education than the users (p < 0.001), 
a n d the f e m a l e s h a d spent m o r e years in education than the m a l e s ( M C s ; p = 
0.005). U s e r s h a d higher B D I scores than the H C s (p < 0.001), w i t h f e m a l e users 
reporting m o r e depression than their m a l e counterparts (p = 0.001). N o sex m a i n 
effect a n d s e x * g r o u p interaction o n B D I scores. N o differences w e r e f o u n d in a n y 
o f the variables for d r u g u s e patterns or severity b e t w e e n f e m a l e a n d m a l e users 
(Table 17). 
T h e sex difference effect o n cognitive functions w a s assessed via 
2 ( s e x ) * 2 ( g r o u p ) analysis o f covariance ( A N C O V A ) , w i t h age, education level a n d 
B D I scores as the covariates. T h e descriptive statistics are presented in T a b l e 18. 
T h e effect size (g
2
) for interactions a n d o b s e r v e d p o w e r are s h o w n in T a b l e 17. T h e 
v a l u e for n
2
 is regarded as a small, m e d i u m a n d large effect size at 0.01, 0.05 a n d 
0.13, respectively [ C o h e n 1988]. A significant s e x * g r o u p effect w a s f o u n d o n 
R O C F d e l a y e d recall (p = 0.040) a n d R O C F savings (p = 0.048), a n d a borderline 
s e x * g r o u p effect o n Digit S y m b o l - C o d i n g (p = 0.081), A r i t h m e t i c (0.073), 
Information (p = 0.058), R O C F i m m e d i a t e recall (p = 0.065) a n d R O C F savings (p 
= 0 . 0 4 8 ) . F o l l o w i n g e a c h borderline or significant interaction, four t-tests w e r e 
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c o n d u c t e d across g r o u p s : f e m a l e users v e r s u s F C s , m a l e users versus M C s , f e m a l e 
users v e r s u s m a l e users a n d F C s versus M C s , w i t h B o n f e r r o n i a d j u s t m e n t for 
multiple c o m p a r i s o n s (a = 0.0125). 
F e m a l e users h a d l o w e r scores o n all o f the a f o r e m e n t i o n e d tests t h a n the F C s 
(all p v a l u e s < 0.001), a n d m a l e users h a d l o w e r D S C (p < 0.001) a n d Information 
(p < 0 . 0 0 1 ) scores than the M C s . F e m a l e users h a d higher D S C scores (p = 0 . 0 1 0 ) 
a n d l o w e r Arithmetic scores (p = 0.004) than m a l e users. T h e y also exhibited 
w o r s e p e r f o r m a n c e than their m a l e counterparts o n R O C F i m m e d i a t e recall (p = 
0.034), R O C F d e l a y e d recall (p = 0.030) a n d R O C F savings (p = 0.026), b u t these 
differences w e r e at the borderline level. 
S e x w a s f o u n d to h a v e a m a i n effect o n L o g i c a l M e m o r y i m m e d i a t e recall (p 
= 0 . 0 1 9 ) , d e l a y e d recall (p = 0.005) a n d recognition (p < 0.001), a n d w o r d list 
i m m e d i a t e recall (p = 0.003), d e l a y e d recall (p = 0 . 0 0 8 ) a n d recognition (p = 
0.026), w i t h f e m a l e s scoring higher than m a l e s overall. F e m a l e s also a c h i e v e d 
higher D S C (p = 0.016) scores than m a l e s , although m a l e s a c h i e v e d higher 
Information a n d R O C F recognition scores (p = 0.014). 
8 1 
CHAPTER 3 RESULTS 3.4 Cognitive functions 
Table 17 Comparison of demographics and drug use patterns among female and male primarily 
ketamine users and healthy controls 
FK MK FC MC P-value 
N = 47 N = 53 N = 42 N = 58 
22.5 ± 4.3 22.3 ± 4.1 21.4 ± 3.4 20.0 ± 3.7 
Education (years) 9 . 9 士 2 . 0 9.3 士 12.4 ± 2.4 11.2 ± 1 3 
1 9 . 6 士 10.. 13.3 ± 9.8 9.2 ± 7.5 士 8. 
SDS 
Age of first use of ketamine 
General duration of drug use 
8.5 士 3 . 2 7.2 士 3. b 
16.4 ± 3.1 17.2 ± 3.2 
5 7 . 5 士 3 1 . 
Days since last use of ketamine (days) 101.2 士 149.4 95.3 士 150.9 
Ketamine use in last month (days) 
Abstained from drug use (days) 
Lifetime ketamine dependence 
Current ketamine dependence 
11.6 9.3 ± 11.8 
80.1 ± 139.8 53.0 ± 110.9 
41 (95.3%) 48 (94.1%) 










Drug use in past 2 years 
Ketamine 432. 426.2 ± 211. 
Any drug 446.4 ± 212.9 437.6 ± 214.2 
Cocaine 11.0 ± 37.8 6.6 ± 17.1 
Methamphetamine 2.7 士 9.6 
Cannabis 1.2 士 5. 
.2 士 15.2 
.9 ± 5. 
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Opioid 0.0 ± 0.0 0.0 ± 0.0 
aANOVA; b t-test; cMann-Whitney U-test; dchi-square test. 
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Table 18 Comparison of cognitive functions among female and male primarily ketamine users and 
healthy controls 
FK MK FC MC g Powe 
N = 47 N = 53 N = 42 N = 58 
WAIS-III DSC 83.8 ± 15.9 75.3 ± 17.2 94.9 ± 91.2 ± 15.5 0.016 0.450 
WAIS-III Arithmetic 11.8± 4.0 14.0 ± 3.9 16.1 ± 3.0 15.7 ± 3.6 0.017 0.398 
WAIS-III Information 10.5 + 3.9 11.4 ± 4.4 13.6 ± 4.5 15.6 ± 4.5 0.018 0.423 
WAIS-III DSF 15.5 ± 0.9 15.4 ± 1.1 15.2 ±1.7 15.2 ± 1.4 0.005 0.141 
WAIS-III DSB 7.9 ± 3. 8.7 ± 3. 9.6 ± 2.8 ± 3.3 0.002 0.106 
WMS-III S Logical Memory: 27.4 ± 12.5 25.1 ± 13.3 40.5 ± 9.0 36.6 ± 0.000 0.050 
immediate recall 
WMS-III Logical Memory: delayed 13.6 ± 25.1 ± 6.5 21.4 ± 7.2 0.000 0.059 
recall 
WMS-III Logical Memory: recognition 23.0 ± 3.6 21.6 ± 3.9 25.4 ± 2.7 24.0 ± 2.9 0.002 0.099 
WMS-III Logical Memory: retention 80.4 ± 20.2 80.4 ± 31.2 88.3 ± 18.1 83.5 ± 16.0 0.002 0.099 
WMS-III Word list: immediate recall 5.4 ± 1 .2 ± 2. 6.3 ± 1 .4 ± 0.007 0.209 
WMS-III Word list: delayed recall 7.6 ± 2.4 7.2 ± 2. 8.8 ± 2.0 8.0 ± 2.2 0.002 0.095 
WMS-III Word list: recognition 22.9 ± 1.7 22.7 ± 1.7 23.4 ± 0.9 23.2 ± 1.0 0.000 0.052 
WMS-III Word list: retention 78.7 ± 28.4 79.0 ± 21.6 84.9 ± 15.4 81.4 ± 0.002 0.100 
ROCF: copy 32.5 ± 3.6 32.9 ± 2.9 33.9 ± 2.2 33.3 ± 2.2 0.004 0.115 
ROCF: immediate recall 17.6 ± 7.0 20.7 ± 7.5 24.5 ± 6.1 22.9 ± 7.2 0.017 0.449 
ROCF: delayed recall 17.8 ± 7.2 20.7 ± 7.3 25.2 ± 4.8 23.4 ± 6.8 0.022 0.539 
ROCF: savings 53.9 ± 20.1 62.4 ± 22.5 74.2 ± 13.0 69.9 ± 0.020 0.528 
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ROCF: recognition 
WCST-trial 
19.8 ± 2.1 20.3 ± 2.6 ± 2.0 21.0 ± 1.7 0.003 0.123 
99.1 + 21.9 94.7 ± 19.3 90.3 ± 20.8 88.4 ± 18.6 0.000 0.053 
WCST-PE 13.8 + 12.0 12.6 ± 10.3 9.4 ± 7.2 0.000 0.052 
WCST-category 
Stroop test: interference (seconds) 
.3 + 士 .7 士 
25.3 ± 8.2 24.5 ± 7.4 
‘± 0.9 0.002 0.082 
± 7.0 21.0 ± 7.1 0.003 0.131 
Stroop test: total reaction time (seconds) 56.3 士 13.0 56.2 士 17.2 49.9 士 12.7 52.6 士 15.0 0.000 0.059 
Stroop test: 3.1 ± 2.2 2.2 ± 21 .9 士 1.8 1 士 0.003 0.130 
MVFT 41.3 ± 9.5 40.5 ± 8.3 47.4 ± 8.1 43.2 ± 9.5 0.001 0.091 
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4.1 Social-Demographics and drug use patterns 
T h e d r u g preferences expressed b y the y o u t h s in this study are consistent 
w i t h the findings o f a recent g o v e r n m e n t report a n d a local study [Narcotics 
Division Security B u r e a u 2 0 1 2 , T a n g et al. 2 0 1 1 ] . K e t a m i n e is their preferred drug, 
f o l l o w e d b y cocaine, m e t h a m p h e t a m i n e a n d hypnotics. Ecstasy, c a n n a b i s a n d 
opioids r a n k last o n the list s h o w n in T a b l e 3. T h e m e a n S D S scores o f the 
Primarily K a n d P o l y K g r o u p s w e r e 7.8 a n d 7.2, respectively, w h i c h indicates a 
severe level o f addiction [ C u e n c a - R o y o et al. 2 0 1 2 ] . T h e s e scores varied f r o m 3 to 
4 in cannabis, a m p h e t a m i n e a n d cocaine users in earlier studies [ G o s s o p et al. 
1 9 9 5 , M a r t i n et al. 2 0 0 6 ] . A n S D S score o f 3/4 is the c o m m o n l y r e c o m m e n d e d 
cut-off for d r u g d e p e n d e n c e [ K a y e a n d D a r k e 2 0 0 2 , M a r t i n et al. 2 0 0 6 , T o p p a n d 
M a t t i c k 1997], w h e r e a s a cut-off score o f 8 h a s b e e n s h o w n to h a v e a specificity o f 
9 8 % in detecting a D S M - I V d e p e n d e n c e diagnosis [ T o p p a n d M a t t i c k 1997]. In 
the s u b g r o u p analyses carried o u t in the current study, the C K g r o u p h a d higher 
craving scores than the C P K group. In the w h o l e g r o u p analyses, lifetime k e t a m i n e 
d e p e n d e n c e w a s r e m a r k a b l y h i g h in b o t h d r u g u s e groups, a r o u n d 9 5 % in the 
Primarily K g r o u p a n d 8 0 % in the P o l y K group, thus revealing a h i g h d e g r e e o f 
k e t a m i n e d e p e n d e n c e . 
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T h e participants in this study w e r e teenagers or y o u n g adults w h o h a d 
b e g u n to u s e d r u g s in m i d d l e school. T h e i r a v e r a g e education level w a s F o r m 3. In 
addition, a p p r o x i m a t e l y 5 0 % w e r e u n a b l e to find (or maintain) a job, a n d their 
a v e r a g e i n c o m e w a s significantly less than that o f the H C s . T h e s e d e m o g r a p h i c 
characteristics are in line w i t h a local report [Narcotics Division Security B u r e a u 
2 0 1 2 ] a n d w i t h m o s t studies in a b r o a d r a n g e o f areas [ D e g e n h a r d t a n d D u n n 2 0 0 8 , 
R e y n a u d - M a u r u p t et al. 2 0 0 7 ] . In t e r m s o f psycho-social factors, there w a s a trend 
that users h a d m o r e m e d i c a l c o m p l a i n s a n d f a m i l y p r o b l e m s , w h i c h is c o m m o n in 
d r u g users [ R o w e 2 0 1 2 , M o r g a n et al. 2 0 1 2 ] . O t h e r factors that related w i t h d r u g 
a b u s e s u c h as personality a n d self-esteem [ K o k k e v i et al. 2 0 0 7 ] w e r e n o t recorded 
in this study, since the m a i n objectives are the cognitive a n d m e n t a l health 
o u t c o m e o f long-term k e t a m i n e use. T h e onset a g e o f c a n n a b i s is generally the 
earliest, w i t h m a n y epidemiological investigations v i e w i n g c a n n a b i s u s e as 
initiating the later u s e o f other d r u g s [ F e r g u s s o n et al. 2 0 0 6 , K a n d e l et al. 2 0 0 6 ] . 
K e t a m i n e u s e h a s also b e e n associated w i t h the u s e o f other psychotropic d r u g s 
[ D e g e n h a r d t a n d D u n n 2 0 0 8 ] . T h e participants in this study preferred to u s e d r u g s 
in the h o m e setting, w h i c h differs f r o m the preferences reported in another earlier 
local study that f o u n d discos a n d bars to b e the m o s t c o m m o n l y cited sites o f 
choice [ C h e n et al. 2 0 0 5 ] . T h e discrepancy m a y reflect a trend t o w a r d s y o u t h d r u g 
a b u s e b e c o m i n g a h i d d e n activity [Narcotics Division Security B u r e a u 2 0 1 2 ] . T h e 
m o s t c o m m o n administration route for k e t a m i n e in H o n g K o n g is still nasal 
inhalation, although t w o studies [ L a n k e n a u a n d S a n d e r s 2 0 0 7 , L a n k e n a u a n d 
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S a n d e r s et al. 2 0 0 7 ] suggest that it is increasingly considered a n injectable 
substance. T h e r e researchers' data are limited to a s u b g r o u p o f injecting d r u g users, 
b u t it is still a n o t e w o r t h y trend. 
4.2 Effects of ketamine on psychological health 
T h e strict criteria for a further psychiatric interview in this study m a y 
explain the relatively l o w attendance rate in b o t h the H C a n d d r u g u s e groups. A 
cut-off point o f 8 o n the B D I a n d 4 o n the H A D S A w e r e u s e d to screen for 
potential m o o d a n d anxiety disorders, although these cut-off points are l o w e r than 
those r e c o m m e n d e d e l s e w h e r e [ B r e n n a n et al. 2 0 1 0 , V i i n a m a k i et al. 2 0 0 4 ] . 
F u r t h e r m o r e , participants w i t h a n y suspected psychotic s y m p t o m s w e r e referred to 
a psychiatrist for further diagnosis. T h e results suggest that the B D I a n d H A D S A 
scores o f those w h o w e r e d e e m e d eligible for a n interview b u t failed to attend w e r e 
l o w e r than those w h o attended a n interview, b u t the differences are n o t statistically 
significant. 
T h e n u m b e r o f participants w i t h a clinical diagnosis did n o t differ 
significantly b e t w e e n the t w o d r u g u s e g r o u p s a n d the H C s , although a notable 
trend t o w a r d s m o r e severe c o m o r b i d psychiatric disorders w a s o b s e r v e d in the 
d r u g users, b o t h pre- a n d post-drug use. B o t h the ex- a n d current primarily 
k e t a m i n e g r o u p s h a d h i g h e r B D I scores than the H C . T h i s result is in k e e p i n g w i t h 
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the a b u n d a n t e v i d e n c e s h o w i n g the c o m o r b i d i t y o f affective disorders a n d 
substance u s e disorders [ C h e n et al. 2 0 0 5 , C o m p t o n et al. 2 0 0 7 , K e s s l e r et al. 1 9 9 6 , 
T a n g et al. 2 0 1 1 , T a n g et al. 2 0 1 1 ] . T h e elevated depression in k e t a m i n e users is 
interesting, since k e t a m i n e h a s a n antidepressant effect [ B e r m a n et al. 2 0 0 0 , Zarate 
et al. 2 0 0 6 ] . H o w e v e r , the cross-sectional design o f this study limits the conclusion 
o f a causality correlation b e t w e e n k e t a m i n e u s e a n d depression. Further, risk 
factors contributing to u s e o f k e t a m i n e or other substances also feed into the 
d e v e l o p m e n t o f depression [ D e g e n h a r d t et al. 2 0 0 3 ] , m a k i n g depression c o m m o n 
in d r u g d e p e n d e n c e [ D a v i s et al. 2 0 0 8 ] . In clinical research, the l o n g - t e r m effects 
o f k e t a m i n e g i v e n as a n antidepressant are largely u n k n o w n [ S z y m k o w i c z et al. 
2 0 1 3 ] . T h e long-term u s e o f k e t a m i n e a n d its association w i t h depression is 
waiting further research. 
P s y c h o t i c disorders, h o w e v e r , w e r e rare in the current s a m p l e , w i t h only 3 % 
o f all d r u g users d i a g n o s e d w i t h s u c h a disorder. A h i g h e r rate o f 6 . 3 % w a s 
reported in another local study [ C h e n et al. 2 0 0 5 ] . A r o u n d 3 0 % o f the participants 
in the current study didn't agree to attend a s e c o n d interview, w h i c h m a y explain 
the l o w e r percentage o f psychotic disorders t h a n that reported elsewhere. S a m p l e 
bias is another possible explanation, that m o s t subjects in this study w e r e recruited 
f r o m c o m m u n i t i e s a n d subjects w i t h m o r e severe complications m a y h a v e less 
c h a n c e to enter into this study. 
4.3 Effects of ketamine on cognitive functions 
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4.3.1 Effects of primarily ketamine use on memory 
B o t h the Primarily K a n d P o l y K g r o u p s s h o w e d cognitive function 
i m p a i r m e n t in a r a n g e o f d o m a i n s w h e n potential c o n f o u n d i n g factors w e r e n o t 
adjusted, w h i c h supports the study's hypothesis. H o w e v e r , there is c o m p e l l i n g 
e v i d e n c e to suggest that cognitive function is affected b y a n u m b e r o f c o n f o u n d i n g 
variables, s u c h as depression a n d education level. D e p r e s s i o n is strongly related to 
cognitive deficits in patients w i t h m a j o r depressive disorders [ L e e et al. 2011], 
p o l y - d r u g abusers [Stevens et al. 2 0 0 7 ] a n d individuals w i t h substance u s e 
disorders [Latvala et al. 2 0 0 9 , Tarter et al. 1995]. E v i d e n c e also suggests that a l o w 
level o f basic education a c c o u n t s for p o o r e r verbal intellectual ability, w h i c h in 
turn contributes to cognitive deficit in substance u s e disorders [Latvala et al. 2 0 0 9 , 
Tarter a n d et al. 1995]. A n o t h e r difference o n d e m o g r a p h i c b e t w e e n users a n d 
controls is age, that users w e r e older than controls. A g e h a s b e e n associated w i t h 
p o o r cognition in aging, w h e r e a s age-related c h a n g e s in cognition in y o u n g e r 
subjects are m u c h less. O n e study reported a g e didn't associate w i t h w o r k i n g 
m e m o r y p e r f o r m a n c e b u t w i t h increased brain activity in y o u n g adult [ A d l e r et al. 
2 0 0 1 ] . C o n s e q u e n t l y , to obtain a m o r e c o n v i n c i n g result, these possible 
c o n f o u n d i n g factors w e r e a d d e d to the multivariate analyses. 
After adjusting for age, sex, education level a n d B D I score, primarily 
k e t a m i n e u s e displayed a unitary influence o n m e m o r y , w h i c h is strikingly 
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consistent w i t h previous findings o n the acute or chronic effects o f this drug. 
E p i s o d i c m e m o r y , visual a n d verbal m e m o r y , a n d short- a n d long-term m e m o r y 
w e r e all affected in the chronic k e t a m i n e users e x a m i n e d in this study. E v i d e n c e 
f r o m healthy volunteers s h o w s a one-off d o s e o f k e t a m i n e to affect the e n c o d i n g o f 
information, w h i c h presents as difficulty in recalling b o t h verbal [ M o r g a n et al. 
2 0 0 4 b ] a n d visual [ O y e et al. 1 9 9 2 ] information. T h e pattern o f m e m o r y 
i m p a i r m e n t f o u n d in the current study c a n also b e t h o u g h t o f as i m p a i r m e n t in the 
e n c o d i n g process o f episodic m e m o r y [ M o r g a n a n d C u r r a n 2 0 0 6 ] . 
T h e current study also f o u n d recent k e t a m i n e u s e to b e i n d e p e n d e n t l y 
related to episodic m e m o r y i m p a i r m e n t , although neither the duration o f k e t a m i n e 
u s e n o r the n u m b e r o f d a y s o f k e t a m i n e u s e in the past t w o years w e r e f o u n d to 
contribute to m e m o r y i m p a i r m e n t after adjusting for c o n f o u n d i n g factors. P r e v i o u s 
reports suggest that the m e m o r y i m p a i r m e n t c a u s e d b y k e t a m i n e u s e is d e p e n d e n t 
o n the extent o f that u s e [Curran a n d M o n a g h a n 2 0 0 1 , M o r g a n et al. 2 0 0 4 b ] . 
H o w e v e r , the a b s e n c e o f a n a c c u m u l a t e d effect o n m e m o r y i m p a i r m e n t suggests 
that m e m o r y m a y recover after a reduction in or cessation o f k e t a m i n e use. T o test 
this a s s u m p t i o n , s u b g r o u p analysis c o m p a r i n g C K s a n d E K s w a s p e r f o r m e d . 
T h e C K g r o u p displayed m e m o r y i m p a i r m e n t relative to b o t h the E K a n d 
H C groups, w h e r e a s there w a s n o difference in i m p a i r m e n t b e t w e e n the latter t w o . 
T h e s e findings are in line w i t h studies reporting i m p a i r m e n t s in w o r k i n g , verbal, 
a n d visual m e m o r y a n d executive function in current k e t a m i n e users [ C u r r a n a n d 
M o n a g h a n 2 0 0 1 , M o r g a n et al. 2 0 0 4 , 2 0 0 9 ] . In the present study, i m p a i r m e n t w a s 
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also d e m o n s t r a t e d in m e n t a l m o t o r speed. A s n o t e d previously, this cognitive 
i m p a i r m e n t r e m a i n e d e v e n after adjusting for the level o f education, a n d s e e m e d to 
b e confined to the C K s . H e n c e , s u c h i m p a i r m e n t is unlikely to b e the result o f 
pre-existing differences in education or intellectual ability. A n alternative 
explanation is that the direct acute and/or chronic effects o f k e t a m i n e c a u s e 
cognitive deficit [ M o r g a n a n d C u r r a n 2 0 0 6 ] . T h e a b s e n c e o f i m p a i r m e n t in the 
E K s also suggests that cognitive i m p a i r m e n t is reversible u p o n cessation o f the 
drug's use, w h i c h is consistent w i t h a p r e v i o u s study [ M o r g a n 2 0 0 9 ] . A recent 
f o l l o w - u p study also f o u n d a correlation b e t w e e n a c h a n g e in k e t a m i n e u s e a n d 
m e m o r y function, b u t n o correlation w i t h other cognitive functions [ M o r g a n et al. 
2 0 1 0 ] . It h a s b e e n suggested that the reversibility o f cognitive i m p a i r m e n t m a y b e 
related to the reversible neurotoxicity o f N M D A R antagonists in a n i m a l m o d e l s 
[Jevtovic-Todorovic et al. 2 0 0 1 ] . A recovery o f cognitive function h a s also b e e n 
o b s e r v e d in the first m o n t h o f abstinence in a g r o u p o f h e a v y alcohol drinkers 
[ D i n g w a l l et al. 2 0 1 1 ] . M o r e robust e v i d e n c e o f the reversibility o f k e t a m i n e ' s 
effect is n e e d e d in future longitudinal studies. 
R e c e n t n e u r o i m a g i n g studies h a v e p r o v i d e d the physiological basis o f 
k e t a m i n e - i n d u c e d cognitive i m p a i r m e n t . In a structural M R I study, L i a o ( 2 0 1 1 ) 
d e m o n s t r a t e d a reduction in the frontal grey matter v o l u m e o f chronic k e t a m i n e 
users [Liao et al. 2 0 1 1 ] , a n d a recent diffusion tensor i m a g i n g study f o u n d w h i t e 
matter abnormalities in the bilateral frontal a n d left temporoparietal regions 
following chronic k e t a m i n e u s e [Liao et al. 2 0 1 0 , 2 0 1 2 ] . A n f M R I study revealed 
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k e t a m i n e - i n d u c e d acute c h a n g e s in the frontal a n d t e m p o r a l cortex [ D e a k i n et al. 
2 0 0 8 ] , a n d a positron e m i s s i o n t o m o g r a p h y ( P E T ) scan f o u n d chronic users o f the 
d r u g to exhibit a n up-regulation o f the d o p a m i n e D 1 receptor in the dorsolateral 
prefrontal cortex [ N a r e n d r a n et al. 2 0 0 5 ] . T h e s e c h a n g e s m a y b e the structural a n d 
functional b a s e s for the o b s e r v e d k e t a m i n e - i n d u c e d i m p a i r m e n t in m e m o r y , 
although to date there is n o n e u r o i m a g i n g e v i d e n c e o n the reversibility o f 
k e t a m i n e ' s effects. 
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4.3.2 Effects of primarily ketamine use on executive functions 
A n a l y s e s c o n d u c t e d in the p o o l e d s a m p l e o f Primarily K users s h o w e d 
w o r k i n g m e m o r y a n d s u c h executive function c o m p o n e n t s as shifting a n d 
inhibition to r e m a i n intact after considering the potential interference o f education 
level a n d depression. H o w e v e r , a w e a k difference w a s f o u n d b e t w e e n the C K 
s u b g r o u p a n d the H C s in w o r k i n g m e m o r y (Arithmetic) a n d the M V F T . H o w e v e r , 
these results are far f r o m sufficient to p r o v e that k e t a m i n e h a s a n effect o n 
executive function. A s w h a t h a s b e e n previously noted, s e m a n t i c fluency is also 
related to s e m a n t i c m e m o r y [ H e n r y a n d C r a w f o r d 2 0 0 4 ] . In fact, studies h a v e 
reported inconsistent results o n k e t a m i n e ' s effects o n executive function. F o r 
e x a m p l e , k e t a m i n e users h a v e b e e n reported to d e m o n s t r a t e intact functioning o n 
the Stroop test [ R o w l a n d et al. 2 0 0 5 ] , c o n t i n u o u s p e r f o r m a n c e task [ N e w c o m e r et 
al. 1 9 9 9 ] a n d Trail M a k i n g a n d 0 - b a c k tests [ M o r g a n et al. 2 0 0 4 a ] , a n d i m p a i r e d 
functioning o n the W C S T [Krystal et al. 2 0 0 0 ] , c o n t i n u o u s p e r f o r m a n c e task 
[Krystal et al. 1994], a n d H a y l i n g test [ M o r g a n et al. 2 0 0 4 b ] . A l t h o u g h notable 
discrepancies exist a m o n g behavioural studies, data f r o m brain i m a g e research 
consistently reveal alterations in the prefrontal region following acute [ D e a k i n et al. 
2 0 0 8 , R o w l a n d et al. 2 0 0 5 ] or repeated k e t a m i n e u s e [Liao a n d T a n g et al. 2 0 1 0 , 
2 0 1 1 , 2 0 1 2 ] . H o w e v e r , o n l y o n e o f these studies e x a m i n e d executive p e r f o r m a n c e , 
a n d f o u n d it to r e m a i n intact after o n e d o s e o f k e t a m i n e [ R o w l a n d et al. 2 0 0 5 ] . T o 
date, there is insufficient e v i d e n c e to p r o v e that k e t a m i n e affects executive 
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processes, although o n e explanation for the discrepancy in research findings is that 
executive function tests c o m m o n l y tap m e m o r y functions, w h i c h m a y b e affected 
b y k e t a m i n e use. H o w e v e r , it should b e w i t h caution to c o n c l u d e that k e t a m i n e 
m a i n l y affects m e m o r y function than executive functions. It is possible that 
k e t a m i n e u s e impairs o n l y a single c o m p o n e n t o f executive function, w h i c h m a y 
n o t m a n i f e s t itself in c o m m o n l y d e s i g n e d tasks [Coull et al. 2 0 1 1 ] . A n o t h e r 
possibility is that s o m e c o m p e n s a t i o n m e c h a n i s m prevents k e t a m i n e users f r o m 
displaying i m p a i r e d p e r f o r m a n c e in executive tasks. T h i s supposition is in line 
w i t h e v i d e n c e suggesting that k e t a m i n e increases P F C activity in p e r f o r m i n g tasks 
that tap w o r k i n g m e m o r y a n d e n c o d e verbal information [ H o n e y et al. 2 0 0 5 a , 
2 0 0 5 b ] . 
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4.3.3 Effects of poly-drug ketamine use on cognitive functions 
C o n t r a r y to the study's hypothesis, P o l y K users s h o w e d n o additional 
i m p a i r m e n t in a n y cognitive d o m a i n c o m p a r e d w i t h the Primarily K users. W h a t is 
m o r e , in the s u b g r o u p analysis, the C K s d e m o n s t r a t e d m o r e severe visual m e m o r y 
i m p a i r m e n t t h a n the C P K s . A l t h o u g h differences in d r u g u s e patterns m a y partially 
explain this finding, in that the P o l y K g r o u p contained m o r e abstainers a n d u s e d 
less k e t a m i n e in the m o n t h before recruitment, another explanation c o u l d b e that 
the severity o f drugs' detrimental m a y also present as the effect duration. A g a i n , 
this hypothesis w a s tested via s u b g r o u p c o m p a r i s o n s b e t w e e n the C P K s a n d E P K s . 
Different f r o m the c o m p a r i s o n s b e t w e e n the C K s a n d E K s , b o t h P o l y K s u b g r o u p s 
displayed episodic m e m o r y i m p a i r m e n t (verbal a n d visual m e m o r y i m p a i r m e n t in 
the C P K s a n d visual m e m o r y i m p a i r m e n t in the E P K s ) , w h i c h indicates that 
abstinence d o e s n o t result in m e m o r y i m p r o v e m e n t s in P o l y K users. Consistent 
w i t h the findings o f this study, researchers h a v e also d o c u m e n t e d continued 
m e m o r y i m p a i r m e n t in ecstasy users after 2 m o n t h s [ Y i p a n d L e e 2 0 0 5 ] , 1 y e a r 
[ H o s h i et al. 2 0 0 7 ] a n d e v e n 2.5 years [ T h o m a s i u s et al. 2 0 0 6 ] o f abstinence. 
F u r t h e r m o r e , c o c a i n e [van G o r p et al. 1999], a m p h e t a m i n e [van H o l s t a n d Schilt 
2 0 1 1 ] a n d p o l y - d r u g [ H o s h i et al. 2 0 0 7 ] users h a v e also s h o w n continued m e m o r y 
deficits after abstinence. T h e current study's finding o f k e t a m i n e - i n d u c e d 
reversible m e m o r y i m p a i r m e n t in p r i m a r y users b u t sustained i m p a i r m e n t in p o l y 
d r u g users, together w i t h the e v i d e n c e o f sustained m e m o r y deficiencies in users o f 
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other d r u g s following abstinence, suggests that the cognitive i m p a i r m e n t is m o r e 
c o m p l i c a t e d in a p o l y - d r u g u s e context a n d m a y n e e d longer t i m e to recover after 
cessation f r o m drugs. 
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C H A P T E R 4 D I S C U S S I O N 4.3 Effects o f k e t a m i n e o n cognitive functions 
4.3.4 Sex-specific effects of ketamine use on cognitive functions 
T h i s is the first study to detect the sex-specific effect o f chronic k e t a m i n e . In 
this study, w o m e n o u t p e r f o r m e d m e n o n m o s t o f the verbal episodic m e m o r y tasks, 
w h e r e a s m e n o u t p e r f o r m e d w o m e n o n the visual m e m o r y recognition task, w h i c h 
is in line w i t h the well-established finding that w o m e n h a v e a d v a n t a g e s in episodic 
m e m o r y , particularly verbal m e m o r y a n d m e m o r y o f object locations, relative to 
m e n , b u t disadvantages in spatial m e m o r y [de Frias et al. 2 0 0 6 , Herlitz et al. 1 9 9 9 , 
L e w i n et al. 2 0 0 1 ] . T h e f e m a l e Primarily K users p e r f o r m e d w o r s e than the F C s o n 
the visual m e m o r y a n d general intelligence tasks, w h e r e a s the m a l e Primarily K 
users p e r f o r m e d m o r e p o o r l y than the M C s only o n the general intelligence tasks. 
T h e r e w a s a w e a k trend for the m a l e Primarily K users to o u t p e r f o r m their f e m a l e 
counterparts o n the visual m e m o r y tasks. A l t h o u g h this pattern is similar w i t h 
pattern in general population, the visual m e m o r y i m p a i r m e n t s w a s only present in 
f e m a l e users w h e r e a s verbal m e m o r y i m p a i r m e n t w a s present in b o t h sexes 
indicates that w o m e n m a y b e m o r e vulnerable to k e t a m i n e - i n d u c e d visual m e m o r y 
i m p a i r m e n t t h a n m e n . In a n earlier study, m a l e healthy volunteers recalled f e w e r 
w o r d s than f e m a l e s in a w o r d learning test after u s i n g k e t a m i n e [ M o r g a n et al. 
2 0 0 6 ] , w h i c h contradicts the findings o f this study. A l t h o u g h m a l e s d e m o n s t r a t e d 
p o o r p e r f o r m a n c e in general, n o differences w e r e f o u n d b e t w e e n the sexes in 
i m p a i r m e n t o n a n y verbal m e m o r y task in this study. O n e explanation for this 
discrepancy m a y b e that the w o r d s M o r g a n et al. [ 2 0 0 6 ] u s e d to test verbal 
9 8 
CHAPTER 4 DISCUSSION 4.3 Effects of ketamine on cognitive functions 
m e m o r y w e r e semantically categorical, w h e r e a s the i t e m s o n the w o r d list u s e d in 
this study w e r e semantically unrelated. T h e f e m a l e a d v a n t a g e in s e m a n t i c 
strategies [Baxter et al. 2 0 0 3 ] m a y partially explain the g e n d e r difference o b s e r v e d 
in M o r g a n et al. [2006]. Differences in the study s a m p l e s also limit the 
comparability o f the t w o studies. 
A recent P E T study in healthy volunteers p r o v i d e s e v i d e n c e o f a 
sex-specific r e s p o n s e to d - a m p h e t a m i n e . D o p a m i n e release w a s f o u n d to b e higher 
in f e m a l e s than m a l e s a n d the latter displayed i m p r o v e d Stroop p e r f o r m a n c e 
following d - a m p h e t a m i n e administration, w h e r e a s that o f f e m a l e s deteriorated 
[Riccardi et al. 2 0 1 1 ] . C h r o n i c k e t a m i n e u s e h a s also b e e n s h o w n to alter 
d o p a m i n e r g i c functioning in the frontal lobe [ N a r e n d r a n et al. 2 0 0 5 ] , although this 
research did n o t e x a m i n e differences b e t w e e n the sexes. M o r e o v e r , there are also 
e v i d e n c e s for sex differences in g l u t a m a t e systems. In a n i m a l studies, f e m a l e rats 
s h o w e d stronger M K 8 0 1 (an a n a l o g u e o f k e t a m i n e ) i n d u c e d - b e h a v i o u r s than 
m a l e s rats ( A n d i n e et al. 1 9 9 9 , Feinstein a n d Kritzer 2 0 1 2 , H o n a c k a n d L o s c h e r 
1993), a n d this effects c a n n o t b e explained b y o n l y the sex different m e t a b o l i z i n g 
capacity o f M K 8 0 1 ( H o n a c k a n d L o s c h e r 1993). T h e findings o f the current study 
p r o v i d e e v i d e n c e to suggest that w o m e n are m o r e susceptible to the effects o f 
k e t a m i n e , highlighting the u r g e n c y o f further research focusing o n the sex-specific 
effects o f this drug. 
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5.1 Limitations 
T h i s study is subject to several limitations. First, the study w a s 
cross-sectional in design, a n d thus the possibility o f pre-existing differences in 
cognitive function c a n n o t b e ruled out. Similarly, the reversibility o f cognitive a n d 
m o o d c h a n g e s r e m a i n s uncertain. Prospective studies o n subjects at h i g h risk o f 
k e t a m i n e u s e or w h o h a v e abstained f r o m k e t a m i n e for s o m e t i m e w o u l d s h e d light 
o n these issues. S e c o n d , although the extent o f u s e o f d r u g s other than k e t a m i n e 
w a s relatively l o w , the possibility that the effects o f these d r u g s c o n f o u n d e d the 
findings c a n n o t b e ruled out. Third, there w e r e differences b e t w e e n the k e t a m i n e 
users a n d controls in t e r m s o f a g e a n d education level, although this issue w a s 
partially resolved t h r o u g h statistical adjustment. Fourth, the k e t a m i n e a n d other 
d r u g u s e status o f the participants w a s b a s e d o n self-reports alone. Fifth, nicotine 
c o n s u m p t i o n w a s n o t r e c o r d e d in this study, a n d a recent study s h o w e d s u c h 
c o n s u m p t i o n to h a v e a protective effect o n cognitive functions after o n e d o s e o f 
k e t a m i n e in healthy volunteers [ K n o t t et al. 2 0 1 2 ] . Finally, s a m p l e m a y h a v e s o m e 
bias that k e t a m i n e users w i t h several comorbidities m a y n o t h a v e equal c h a n c e to 
enter into this study. T h i s m a y limit the generalization o f conclusions. 
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5.2 Conclusion 
C o c a i n e a n d m e t h a m p h e t a m i n e w e r e f o u n d to b e the m o s t c o m m o n l y 
a b u s e d d r u g s after k e t a m i n e in the k e t a m i n e - u s i n g s a m p l e s considered in this 
study. P r i m a r y a n d p o l y - d r u g k e t a m i n e users w e r e f o u n d to exhibit similar 
k e t a m i n e u s e patterns. Consistent w i t h the study's hypothesis, b o t h the Primarily K 
a n d P o l y K g r o u p s d e m o n s t r a t e d m e m o r y i m p a i r m e n t s and, to a lesser extent, 
executive function i m p a i r m e n t s . K e t a m i n e u s e severity in the m o s t recent m o n t h 
w a s negatively correlated w i t h m e m o r y functions. B o t h d r u g u s e g r o u p s exhibited 
m o r e s y m p t o m s o f depression than the H C s , particularly those currently u s i n g 
drugs. H o w e v e r , the D S M - I V d i a g n o s e s w e r e consistent across groups. C o n t r a r y 
to expectations, the P o l y K users did n o t display m o r e severe cognitive i m p a i r m e n t 
than the Primarily K users. After the cessation o f k e t a m i n e , Primarily K users 
d e m o n s t r a t e d similar cognitive functioning to the H C s , w h e r e a s their P o l y K 
counterparts continued to s h o w deficiencies. In line w i t h expectations, f e m a l e 
Primarily K users w e r e f o u n d to h a v e p o o r e r visual m e m o r y functions than their 
m a l e counterparts. T h i s study p r o v i d e s strong e v i d e n c e o f the h a r m f u l effects o f 
chronic k e t a m i n e u s e o n b o t h psychological well-being a n d cognitive functions. 
Further studies w i t h a longitudinal or prospective design will help to strengthen the 
e v i d e n c e presented here o n the reversibility o f k e t a m i n e - i n d u c e d m e m o r y 
i m p a i r m e n t a n d identify the m e c h a n i s m b y w h i c h that reversal takes place. Further 
research is also n e e d e d to clarify the sex-specific effects o f k e t a m i n e in b o t h their 
clinical a n d biological manifestations. 
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